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Abstract    
The  respiratory  mucosa  is  continuously  exposed  to  a  myriad  of  pathogens  and 
allergens that are inhaled during respiration. B cells of the immune system produce 
immunoglobulin  A  (IgA)  that  protects  the  respiratory  mucosa  from  inhaled 
pathogens and allergens.  IgA is  produced after naïve  B  cells  undergo  activation, 
proliferation and differentiation, developing into antibody producing plasma cells. 
The process that facilitates IgA production as B cells develop into plasma cells is 
known as class switch recombination (CSR).  
Factors  favouring  IgA  have  been  determined  by  in  vitro  studies  of  CSR.  These 
established  two  cytokines,  IL-21  and  TGF-β1,  to  be  important  factors  for  IgA 
production. Prior studies with human naïve B cells that were cultured with IL-21 and 
TGF-β1,  in  addition  to  anti-IgM,  anti-CD40,  IL-2  and  CpG,  developed  into 
precursors  of  IgA  producing  plasma  cells  (plasmablasts)  that  possessed  mucosal 
homing capabilities: a process termed B cell conditioning.  
The aim of this project was to establish whether the same factors were active on 
murine naïve B cells in order to eventually test the in vivo therapeutic potential of B 
cell conditioning. A protocol was optimised for CD19
+CD27
- naïve B cell isolation 
from  mouse  spleen  and  cell  division,  which  is  crucial  for  IgA  CSR,  by  CFSE 
labelling and flow cytometry. The number of divisions predicts the generation of IgA 
mucosal  homing  plasmablasts  in  vitro.  Cells  were  found  to  have  undergone  5 
divisions after 7 days in  culture suggesting that  cells  had undergone  a sufficient 
number of divisions for CSR and IgA production. Attempts were made to quantitate 
IgA production in culture supernatants, however evidence for the generation of these 
cells by IgA production remains to be confirmed. The results of this project provide Conditioning Murine B Cells for Immunoglobulin A Production 
 
  iv 
preliminary evidence that murine naïve B cells can be conditioned in vitro for IgA 
production, with potential for homing to, and protection of, mucosal surfaces in vivo. 
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Chapter 1.  Literature Review and Introduction 
The  lung  is  constantly  exposed  to  a  myriad  of  pathogens  and  allergens  that  are 
inhaled  during  respiration.  Respiratory  diseases  develop  when  these  pathogens 
breach the protective mechanisms of the lung and successfully establish infections 
(Snelgrove  et  al.,  2011).  Acute  infections  of  the  lower  respiratory  tract  are  the 
leading  cause  of  childhood  mortality  and  morbidity  (Lim  et  al.,  2006).  These 
respiratory infections are caused by viruses (e.g. influenza virus) and bacteria (e.g. 
Streptococcus  pneumonia  and  Haemphilus  influenzae),  which  often  result  in  the 
development  of  bronchiolitis  or  pneumonia  (Lim  et  al.,  2006).  Antibiotics  are 
commonly used as a pharmacological treatment of bacterial respiratory infections. 
However, the development of multiple antibiotic resistant bacteria is on the rise. For 
instance,  53.2%  of  S.  pneumoniae  strains  in  Asia  are  resistant  to  three  of  the 
following antibiotics: β-lactams, macrolides, tetracyclines, phenicols, folate-pathway 
inhibitors and quinolones (Lim et al., 2006). Consequently, there is a growing need 
for the development of alternative forms of protection against respiratory infection. 
Prophylactic  vaccination,  which  induces  immune  protection  by  the  production  of 
antibodies (Tamura and Kurata, 2004), is one such alternative strategy for tackling 
respiratory infection. 
In this paradigm, antibodies that protect against viruses and bacteria are produced by 
plasma cells,  an immune cell type within the body. Antibodies  confer  protection 
against  viruses  and  bacteria  by  binding  physically  to  them,  thereby  preventing 
contact  between  these  pathogens  and  the  lung,  which  is  essential  for  the 
establishment  of  antibodies    (Brandtzaeg,  1992).  A  recent  report  documenting 
successful generation of human antibody producing plasma cells in vitro (Dullaers et Chapter 1.                                                                                                    Literature Review and Introduction 
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al., 2009) has provided support for the therapeutic application of these cells in the 
treatment of the respiratory diseases. Establishing a similar protocol for generating 
murine plasma cells in vitro was the overall focus of this project. 
1.1  Organisation of the Respiratory Tract  
The respiratory tract can be divided into two distinct regions: the conducting zone 
(airway passages) and respiratory zone (lung parenchyma). The conducting airways 
begins at the nasal passage and terminate at the terminal bronchioles (Pilette et al., 
2001). The primary function of the conducting airways is to condition inhaled air for 
gas  exchange  in  the  parenchyma.  Air  passing  through  the  conducting  airways  is 
warmed,  moistened,  and  filtered  for  foreign  particulates  and  microbes  before 
entering the respiratory bronchioles, alveolar ducts, alveolar sacs and alveoli  that 
make up the lung parenchyma (Hyde et al., 2009). Under homeostatic conditions, the 
normal  function  of  the  conducting  airways  and,  alveolar  macrophages  (pathogen 
engulfing  immune  cells)  in  the  lung  parenchyma,  maintain  a  sterile  environment 
within the respiratory tract.  
1.2  Respiratory Mucosal Protection From Infections and Allergens 
The respiratory mucosa covers the surface of the lungs, nasal and oral cavity. At 
approximately 100 m
2 in adult humans, it forms the second largest mucosal surface 
within the body after the gastrointestinal tract (GIT) (Figure 1.1). Given the absolute 
requirement for constant gas exchange (between 1000 and 2100 litres a day) the 
respiratory mucosa becomes constantly exposed to the external environment. As such, 
the respiratory mucosa is a primary portal of entry for many potentially infectious 
pathogens  that  are  inhaled  during  respiration  (Wanner  et  al.,  1996).  The  risk  of 
infections is greatly augmented given the rich vascularization of the lungs. In order Chapter 1.                                                                                                    Literature Review and Introduction 
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to  facilitate  unimpeded  gas  exchange  during  respiration,  many  blood  vessels  are 
situated in close proximity to the external environment, becoming potential channels 
for pathogen infection and dissemination (Holt et al., 2008). Aside from infections, 
there is also the potential of developing allergic responses (i.e. asthma) to common 
allergens  (Sato  and  Kiyono,  2012).  These  risks  are  kept  in  check  by  physical, 
chemical  and  immunological  mechanisms  along  the  respiratory  tract.  Efficient 
mucosal  protection  requires  complex  interactions  and  coordination  between  these 
mechanisms. 
 
Figure  1.1 Mucosal surfaces of the body. These surfaces are in direct contact with the external 
environment  and  are  constantly  exposed  to  foreign  particles  and  pathogens.  The  sterile  internal 
environment of the body is shaded in blue. 
 
1.3  Physical and Chemical Protection of the Respiratory Mucosa 
The respiratory mucosa, comprised of an epithelial layer and an underlying layer of 
loose connective tissue known as the lamina propria, serves as an anatomical barrier 
that  separates  the  sterile  internal  milieu  from  the  external  environment  (Reznik, 
1990). Adhesion complexes (tight junctions, adherens junctions and desmosomes) 
between epithelial cells maintain epithelial integrity (Figure 1.2), thereby preventing Chapter 1.                                                                                                    Literature Review and Introduction 
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paracellular (between cell) passage of foreign antigens across the mucosa (Anderson 
and Van Itallie, 1995). However, the efficacy of mechanical protection decreases as 
ciliated pseudostratified epithelia in the conducting airways  transition into simple 
squamous epithelia in the lung parenchyma to facilitate gas exchange (Tam et al., 
2011). As such, protection at the level of the lung parenchyma relies more heavily on 
immunological aspects of the respiratory mucosa (Holt et al., 2008). 
The mucociliary escalator is another component of physical protection. It lines the 
entire surface of the trachea and parts of the bronchial tree (conducting airways) and 
is  comprised  of  a  mucous  layer  into  which  beating  cilia  are  projected  from  the 
surface of underlying epithelial cells (Wanner et al., 1996). The mucous layer traps 
inhaled pathogens and allergens while constant ciliary motion transports them away 
from the lungs (Figure 1.2). This ongoing process of mucous secretion and transport 
is known as mucociliary clearance and ensures the continuous removal of inhaled 
pathogens and allergens, thus maintaining sterility within the airways (Kim et al., 
1997).  
 
Figure 1.2 Mucociliary escalator of the respiratory tract. Bacteria in the airways become trapped 
in the mucous layer and removed by beating cilia. Adhesion complexes hold adjacent respiratory 
epithelial cells together to prevent pathogen invasion and subsequent infection. Chapter 1.                                                                                                    Literature Review and Introduction 
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Various  chemicals  released  by  specific  cells  within  the  respiratory  mucosa 
complement  the  mucosal  protection  conferred  by  physical  mechanisms. 
Antimicrobial peptides are released into the lumen of the airways and mucous layer 
by respiratory epithelial cells in response to the presence of bacteria, yeasts, fungi 
and  viruses.  Comprised  mainly  of  small  cationic  molecules,  the  three  important 
classes  of  antimicrobial  peptides  are  defensins,  cathelicidins  and  histatins.  The 
primary  function  of  these  peptides  is  to  induce  cell  death  by  destabilising  the 
pathogen membrane  (reviewed by De Smet and Contreras, 2005).   
1.4  Immunological Protection of the Respiratory Mucosa 
Respiratory mucosal  immunity is  mediated by  numerous  immune cell types.  The 
immune  responses  mediated  by  these  cells  ensure  effective  surveillance  and 
pathogen removal, maintaining immunological homeostasis within the lungs (Holt et 
al.,  2008).  All  immune  responses  generated  against  pathogens  and  allergens 
encountered  at  the  respiratory  mucosa  can  be  broadly  classified  into  innate  and 
adaptive mucosal responses.  
1.4.1  Innate Mucosal Responses 
The  primary  role  of  innate  mucosal  responses  is  to  remove  common  pathogens 
efficiently. As such, the responses tend be less pathogen specific, but are initiated 
more  quickly  than  adaptive  responses.  Complement  proteins,  macrophages, 
granulocytes  (neutrophils,  eosinophils  and  basophils),  mast  cells,  dendritic  cells 
(DCs) and natural  killer (NK) cells  are the primary mediators of innate mucosal 
responses. Respiratory epithelial cells have also been found to initiate innate mucosal 
immune responses (reviewed by Parker and Prince, 2011). The primary responses, 
mediated collectively by these cells include cell lysis, opsonisation, phagocytosis, Chapter 1.                                                                                                    Literature Review and Introduction 
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immune cell recruitment and inflammation (Abrutyn et al., 1977; Gin et al., 1984; 
Watford et al., 2000; Carroll, 2004; Bolger et al., 2007; Aleshin et al., 2012). 
Resident  DCs  are  antigen  presenting  cells  in  the  respiratory  mucosa,  which  are 
known as airway mucosal DCs (AMDCs). These cells assume an additional role of 
initiating adaptive immune responses. After internalising pathogens and processing 
them into antigenic peptides, AMDCs migrate to regional lymph nodes within the 
lungs. The peptides are then presented to T cells of the adaptive immune system, 
which then proceed on to elicit various adaptive responses (Jahnsen et al., 2006). As 
such,  AMDCs  in  general  are  regarded  as  an  essential  link  between  innate  and 
adaptive  respiratory  mucosal  immune  responses  (reviewed  by  Hammad  and 
Lambrecht, 2011).  
1.4.2  Adaptive Mucosal Immune Responses 
The adaptive mucosal immune system reinforces responses initiated by the innate 
immune system. Although both systems are activated simultaneously upon antigen 
encounter, the adaptive immune system takes  a longer time to mount its specific 
immune responses. These responses are initiated by antigen presentation by DCs that 
have trafficked antigen to secondary lymphoid tissues such as the lymph nodes (LNs). 
Macrophages, epithelial cells and other DC subsets can also initiate adaptive mucosal 
responses by antigen presentation, albeit to a lesser degree compared to AMDCs.  
Adaptive mucosal immune responses are mediated by B and T cells that develop 
from precursor cells in the bone marrow and thymus respectively. These cells have 
high pathogen specificity and are thus able to remove pathogens more effectively. 
Compared to innate responses, adaptive responses take longer to initiate due to the 
time required for proliferation of antigen-specific B and T cells (clonal expansion) Chapter 1.                                                                                                    Literature Review and Introduction 
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following antigen presentation in secondary peripheral lymphoid tissues (reviewed 
by Medzhitov, 2007).  
Immune Function of Effector T Cells 
Effector T cells are cells that have recognised cognate antigens presented by DCs and 
undergone  clonal  expansion  and  differentiation.  Most  effector  T  cells  can  be 
categorised into two broad classes, CD8+ and CD4+ T cells. CD4+ T cells can be 
further categorised into several functional subsets based on the release of different 
but  overlapping  cytokines  (small  soluble  proteins  secreted  by  cells)  and/or  the 
expression of surface markers. The CD4+ T cell subsets include T helper (TH) 1 cells, 
TH2,  TH9,  TH17,  regulatory  T  (Treg)  cells  and  T  follicular  helper  (TFH)  cells  
(reviewed by Nakayamada et al., 2012) (Figure 1.3). 
The CD4+ effector T cells described above control almost all of the known effector 
mechanisms of the adaptive mucosal immune response (reviewed by Bennett et al., 
1998; Luckheeram et al., 2012). In contrast, CD8 effector T cells, also known as 
cytotoxic T cells or cytotoxic lymphocytes (CTLs), participate directly in adaptive 
mucosal  responses.  These  cells  are  able  to  distinguish  host  cells  that  have  been 
infected by viruses or intracellular pathogens, removing only the infected cells by 
inducing apoptosis (reviewed by Russell and Ley, 2002). Chapter 1.                                                                                                    Literature Review and Introduction 
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Figure  1.3  CD4+  T  cell  subsets.  Each  subset  produces  a  unique  profile  of  cytokines  and  are 
responsible for mediating a range of adaptive responses.  
 
CD4+  T  cells  provide  essential  signals  known  as  cytokines  that  influence  the 
response  of  other  immune  cells,  thereby  indirectly  mediating  a  wide  range  of 
adaptive mucosal responses. The adaptive responses mediated by TH1 and TH2 cells 
target bacterial and parasitic infections respectively (Yap et al., 2000; Pesce et al., 
2006).  While  TH9  and  TH17  cells  enhance  inflammatory  responses  (reviewed  by 
Korn et al., 2009; Wilhelm et al., 2011), Treg cells mediate responses that dampen 
inflammation (reviewed by Fontenot and Rudensky, 2005). TFH cells are specialised 
at  mediating  humoral  immunity,  immunity  that  is  conferred  by  the  function  of 
antibodies.  This  is  achieved  indirectly  by  the  production  of  cytokines  that  direct 
antibody production by B cells (reviewed by King et al., 2008) 
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Function of Effector B Cells 
Effector  B  cells  within  the  respiratory  mucosa  are  termed  mucosal  plasma  cells, 
which  produce  antigen  specific  antibodies  that  mediate  pathogen  removal  from 
mucosal  sites  (Shapiro-Shelef  et  al.,  2003).  Mucosal  plasma  cells  can  produce 
antigen specific antibodies of various isotypes that include immunoglobulin (Ig) M, 
IgD,  IgG,  IgE  and  IgA.  These  isotypes  are  produced  and  distributed  in  varying 
abundance within the respiratory mucosa, performing distinct immune functions that 
form  part  of  the  adaptive  mucosal  immune  responses  (Brüggemann  et  al.,  1987; 
Slifka et al., 1998). The antibody isotype primarily involved with the protection of 
mucosal surfaces is IgA (Chen and Li, 1990). As for naive T cells described above, 
naive B cells must first be activated by cognate antigen before differentiation into 
antibody producing plasma cells, and this will be discussed further in Section 1.7 
below. 
1.5  Immune Sites of the Respiratory Mucosa 
The immune system of the respiratory mucosa, like that of other mucosal surfaces, 
can be divided into two distinct sites, inductive sites and effector sites (Figure 1.4). 
Inductive  sites  are  where  immune  responses  are  initiated.  Effector  sites  located 
nearby are where immune cells perform their immune effector functions (reviewed 
by Kiyono and Fukuyama, 2004).  Chapter 1.                                                                                                    Literature Review and Introduction 
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Figure 1.4 Inductive and effector site of mucosa-associated lymphoid tissue. At inductive sites, 
antigen presentation to naïve lymphocytes triggers an adaptive immune response. Migrating to nearby 
effector sites via the blood circulation, activated B and T cells differentiate terminally into effector 
plasma and CD4+ helper T cells respectively. Antibodies synthesised by plasma cells are secreted into 
the external environment to confer mucosal protection (adapted from Kiyono and Fukuyama, 2004). 
 
1.5.1  Inductive Sites 
Inductive  sites  are  located  strategically  within  the  respiratory  mucosa  such  that 
immune responses against infectious pathogens encountered at the mucosal surface 
can be initiated promptly. The primary inductive site within the lungs is the mucosa 
associated lymphoid tissue (MALT). Thoracic lymph nodes (LNs), which are located 
further  away  from  the  mucosal  surface  than  respiratory  MALTs,  also  serve  as 
inductive  sites  (Suwatanapongched  2006).  The  cells  and  mechanisms  in  place  at 
these sites actively sample the airways for pathogens and mount efficient adaptive 
mucosal responses when infectious pathogens are encountered.  
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Lymph Nodes (LNs) 
Thoracic LNs form the first group of inductive sites. In humans, these are comprised 
of the hilar, paratracheal, tracheobronchial and intrapulmonary group of LNs that are 
located  along  the  respiratory  tract  (Suwatanapongched  2006).  These  LNs  are 
surrounded by a fibrous capsule and the distribution of immune cells within (Figure 
1.5) is similar to that of MALTs. B cells are localised within B cell follicles present 
in  the cortical  region  of  LNs. T  cells and  DCs  are more diffusely distributed  in 
paracortical areas surrounding the follicles. LNs, unlike MALTs, receive an afferent 
lymphatic supply and thus do not sample pathogens directly from the airways. As 
such,  the  induction  of  adaptive  immune  responses  within  LNs  relies  on  the 
interactions between circulating lymphocytes and migratory DCs (reviewed by Cook 
and Bottomly, 2007).  
 
Figure 1.5 Structural organisation of a lymph node. B cells are located within the follicles, while T 
cells and dendritic cells (DCs) are located in the paracortical area. (adapted from Murphy, 2012) 
 
Mucosal Associated Lymphoid Tissue (MALT) 
MALTs of the respiratory mucosa are located within the lamina propria layer and can 
be  anatomically  divided  into  bronchus-associated  lymphoid  tissue  (BALT), Chapter 1.                                                                                                    Literature Review and Introduction 
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nasopharynx-associated lymphoid tissue (NALT) and Waldeyer’s pharyngeal ring. 
The  appearance,  distribution  and  composition  of  respiratory  MALTs  vary 
dynamically in accordance with species, age and extent of infection (reviewed by 
Brandtzaeg et al., 2008).  
MALTs  of  the  lungs  have  highly  organised  microenvironments  that  facilitate 
efficient antigen detection and the subsequent initiation of adaptive responses (Figure 
1.6). Lymphoid follicles (dense and non-capsulated aggregations of immune cells) 
are overlaid by specialised follicle associated epithelium (FAE). Most B cells are 
located within the follicles, while T cells reside mainly in T cell zones that surround 
the follicles (Korsrud and Brandtzaeg, 1980). Other immune cells such as dendritic 
cells  and  macrophages  are  also  present  in  respiratory  MALTs,  albeit  in  less 
distinguishable regions (Tang et al., 1995; Lugton, 1999).   
Respiratory MALTs actively sample antigens from the airways (Fujimura, 2000). For 
instance in the Waldeyer’s ring, antigens are actively sampled through deep antigen-
retaining  crypts  that  are  directly  exposed  to  the  airways  (Tang  et  al.,  1995). 
Specifically, thin non-secretory microfold cells (M cells) scattered across the FAE 
transfer antigens directly from the airways into the underlying tissues where immune 
cells are closely juxtaposed (Morin et al., 1994; Kim et al., 2011). This direct transfer 
immediately exposes sampled antigens to the immune cells, allowing rapid induction 
of adaptive immune responses (reviewed by Neutra, 1998). Chapter 1.                                                                                                    Literature Review and Introduction 
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Figure 1.6 Structural organisation of the mucosa-associated lymphoid tissue. Microfold (M) cells 
present in the follicular associated epithelium (FAE) transfer antigens directly from the airways into 
underlying  tissues  where  B  cells  and  T  cells  are  located  nearby.  Dendritic  cells  (DCs)  at  the 
respiratory epithelia can sample antigens directly and transport them to lymph nodes (LNs).   
  
1.5.2  Effector Sites 
The mucosal epithelia and its underlying lamina propria form the effector sites of the 
airways. Effector cells are scattered at these sites, resulting in poorly defined cellular 
compartments. Plasma cells and CD4+ T cells are abundant within the lamina propria 
making up the primary effector cell types mediating most of the immune responses 
against pathogens (reviewed by Holt et al., 2008). CD8+ bronchial intraepithelial 
lymphocytes (IELs)  are interspersed  among  epithelial cells  within the  respiratory 
mucosa. These cells secrete cytokines that inhibit epithelial growth and reduce viral 
replication activity (Hirosako et al., 2009; Hirosako et al., 2010).  Chapter 1.                                                                                                    Literature Review and Introduction 
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1.6  Naïve B Cell Development and Maturation into Mucosal Plasma 
Cells  
Naïve B cells are derived from hematopoietic stem cells (HSCs) in the bone marrow. 
Early  naïve  B  cell  development  occurs  within  the  bone  marrow,  while  later 
development into naïve B cells occurs in the spleen. Fully functional naïve B cells 
emerge from the spleen after maturation and circulate throughout the body in search 
of  cognate  antigens  using  specific  B  cell  receptors  (BCRs)  expressed  on  their 
surfaces.  They  become  activated  when  their  BCRs  engage  antigens  and  undergo 
clonal  expansion,  differentiation  and  migration,  developing  into  mucosal  plasma 
cells (Shikina et al., 2004; Fleire et al., 2006). These cells produce large quantities of 
antibodies,  especially  IgA,  that  mediate  pathogen  removal  at  mucosal  surfaces. 
Mucosal plasma cells become quiescent memory B cells when the pathogens are 
successfully removed, although upon repeat pathogen encounter, memory B cells 
revert back into plasma cells. 
1.6.1  Development of Naïve B Cells 
Naïve B cell development occurs in two phases, each in a different lymphoid tissue. 
The first phase occurs in the bone marrow where immature B cells develop from 
dividing  and  differentiating  HSCs  (Hardy  et  al.,  1991;  Tokoyoda  et  al.,  2004). 
Commitment to B cell development in the bone marrow is marked by the expression 
of B cell receptors (BCRs) on the surface of naïve B cells (Hardy et al., 1991). These 
receptors, predominantly of the IgM isotype, are essential for naïve B cell function as 
they are involved in pathogen recognition and binding (Fleire et al., 2006). As the 
BCRs  expressed  on  each  B  cell  recognise  a  specific  antigen,  naïve  B  cells  as  a 
population have varied antigen specificities (Hardy and Hayakawa, 2001). Immature 
B cells emerging from the bone marrow migrate to the spleen where they undergo Chapter 1.                                                                                                    Literature Review and Introduction 
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the  second  phase  of  development  and  mature  into  fully  functional  naïve  B  cells 
(Loder et al., 1999; Cariappa et al., 2007).  
Naïve B cells are delineated by anatomical location, function and phenotypic marker 
expression (Sagaert and De Wolf-Peeters, 2003). Three different subsets of naïve B 
cells, B1, B2 (conventional) and marginal zone (MZ), have been identified in mice. 
Similar  attempts  with  human  naïve  B  cells  have  garnered  some  success  in  the 
identification of the B2 and “MZ-like” subsets but not the B1 subset (Sagaert and De 
Wolf-Peeters, 2003).  
1.6.2  Naïve B Cell Activation 
Naïve B cells emerging from the spleen circulate to different lymphoid tissues in 
search of their cognate antigens. Those that bind to their cognate antigens become 
activated and undergo clonal expansion and differentiation, while those that fail to do 
so either migrate to other lymphoid follicles in search of cognate antigens or undergo 
apoptosis  (Yi  et  al.,  1998;  Do  et  al.,  2000).  Antigen  binding  occurs  via  B  cell 
receptors (BCRs) and toll-like receptors (TLRs) expressed on the surface of these 
cells. TLRs, unlike BCRs, are less antigen specific, binding to structures that are 
conserved amongst many pathogens (Bernasconi et al., 2003). Nevertheless, antigens 
that  bind  to  either  receptor,  in  combination  with  various  intracellular  signalling 
pathways,  trigger  the  transcription  of  genes  that  direct  B  cell  division  and 
differentiation (Pone et al., 2012). Naïve B cells can be activated in two ways, with 
(T cell dependent) or without (T cell independent) help from T cells.  
1.6.2.1 T Cell Independent Activation  
T  cell  independent  (TI)  activation  occurs  less  frequently  than  T  cell  dependent 
activation, with naïve B cells achieving full activation by antigen binding alone. TI Chapter 1.                                                                                                    Literature Review and Introduction 
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activation can be further classified into two types, Type 1 TI and Type 2 TI (Bessa 
and Bachmann, 2010).   
Naïve B cells that undergo Type 1 TI activation receive activation signals from both 
BCRs and TLRs (Pone et al., 2012). There are 13 types of TLRs, each recognising 
different groups of pathogens. TLR signalling results in the production of primary 
transcription factor nuclear factor kappa B (NFκB), which initiates the transcription 
of genes required for B cell proliferation and differentiation (Barton and Medzhitov, 
2003).  Lipopolysaccharide (LPS), a component of bacterial membranes, activates 
naïve  B  cells  via  TLR4  (Kalis  et  al.,  2003).  Cytosine-phosphate-guanine  (CpG) 
dinucleotides, which are closely associated with pathogen DNA, activates naïve B 
cells by binding to TLR9 (Pone et al., 2012).  
Naïve B cells undergoing Type 2 TI rely only on extensive BCR cross-linking for 
complete activation. The antigens that activate naïve B cells in this manner are often 
large polysaccharides that possess multiple binding sites for efficient BCR cross-
linking,  thereby  providing  sufficient  signals  for  activation  (Obukhanych  and 
Nussenzweig, 2006).  
1.6.2.2 T Cell Dependent Activation 
Most naïve B cells that bind antigens via their BCRs only become partially activated, 
requiring  co-stimulatory  signals  from  TH  for  complete  activation.  These  partially 
activated B cells receive these secondary signals after presenting processed antigens, 
via  major  histocompatibility  complex  class  II  molecules  (MHC  class  II),  to 
respective TH cells (Okada et al., 2005). TH cells provide two types of co-stimulatory 
signals, CD40 ligand (CD40L) and cytokines known as interleukins (ILs). CD40L 
expressed on the surface of T cells bind to CD40 expressed on B cells after antigen Chapter 1.                                                                                                    Literature Review and Introduction 
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binding  (Noelle  et  al.,  1992).  Interleukins,  such  as  IL-2  and  IL-4,  bind  to  their 
receptors expressed on B cells and trigger or alter intracellular signalling pathways, 
directing effector B cell development (Waldmann et al., 1984; Flynn et al., 1998). 
1.6.3  Germinal Centre Reactions Generate Plasmablasts  
Activated  B  cells  within  specialised  microenvironment  of  GCs  undergo  clonal 
expansion  and  differentiation  and,  later  emerge  as  plasmablasts  (PBs)  that 
differentiate  into  long-lived  plasma  cells.  The  processes  associated  with  clonal 
expansion and differentiation within GCs are collectively referred to as GC reactions 
(Klein et al., 2003; Nojima et al., 2011).  
GCs contain light and dark zones that can be distinguished in relation to specific 
processes associated with cell proliferation and gene modification (Allen et al., 2004). 
Light  zones  are  where  B  cells  temporarily  cease  dividing  and  undergo  selection 
based on their ability to bind antigens presented by follicular dendritic cells (FDCs) 
(Allen and Cyster, 2008). B cells within light zones (centrocytes) rely on signals 
provided by TFH, such as IL-21 and transforming growth factor-beta 1 (TGF-β1) for 
growth and further development (Bryant et al., 2007; Dullaers et al., 2009; Kerfoot et 
al.,  2011).  Activated  B  cells  within  dark  zones  (centroblasts)  undergo  clonal 
expansion (Barnett et al., 2012). Within the dark zones, centroblasts undergo two 
gene modification processes that occur in association with clonal expansion. After 
cycling between these two zones, which is mediated by the expression of CXCR4 
and CXCR5, PBs (precursor plasma cells) emerge from the GC (Allen et al., 2004). 
These cells possess BCRs of different isotypes, which are released in small amounts 
as  antibodies.  The  amount  released  is  greatly  increased  when  PBs  terminally Chapter 1.                                                                                                    Literature Review and Introduction 
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differentiate  into  plasma  cells  following  migration  to  immune  effector  sites 
(Tarlinton et al., 2008). 
1.6.3.1 Somatic Hypermutation 
Somatic hypermutation (SHM) causes random point mutations in genes coding for 
the  variable  binding  region  of  BCRs,  thus  diversifying  the  antigen  recognition 
capability of BCRs (Zan et al., 1999; Weiser et al., 2011). SHM is initiated by the 
enzyme,  activation-induced  deaminase  (AID)  (Muramatsu  et  al.,  2000).  The 
expression of this enzyme is initiated during naïve B cell activation via intracellular 
signalling pathways (Dedeoglu et al., 2004). AID converts cytidine in the target gene 
into uracil, causing a mismatch between complementary copies of the gene (Maul et 
al.,  2011).  Uracil  is  removed  by  the  enzyme  uracil-DNA  glycosylase  (UNG), 
triggering base excision repair (BER), which creates a single-stranded break (SSB) in 
the  DNA  (Rada  et  al.,  2002).  Resolution  of  the  break  by  error-prone  DNA 
polymerases, which introduce bases other than cytidine, thus  generates a random 
point mutation (Delbos et al., 2005). Single point mutations alter the conformation of 
the variable binding region of BCRs, which ultimately affects the antigen recognition 
capabilities and antigen binding affinities of these receptors (Zan et al., 1999; Weiser 
et al., 2011). As such, SHM diversifies the BCRs expressed on centroblasts. 
1.6.3.2 Class Switch Recombination 
Class switch recombination (CSR) is a gene modification process that allows BCRs 
to switch from the default IgM isotype to other isotypes. Like SHM, CSR is also 
initiated by the same enzymatic actions of AID described above (Muramatsu et al., 
2000). However, AID alone does not determine the isotype that will be switched to 
during CSR. Additional signals received during activation, primarily in the form of Chapter 1.                                                                                                    Literature Review and Introduction 
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cytokines, are required for directing class-switching to a specific type (Reinhardt et 
al., 2009).  
Cytokines mediate the growth and differentiation of activated B cells into plasma 
cells by binding to their respective receptors that are expressed on B cells (Kehrl et 
al.,  1986;  Parrish-Novak  et  al.,  2000).  Two  cytokines,  IL-21  and  TGF-β1,  are 
responsible for IgA class-switching and subsequent IgA production (Parrish-Novak 
et  al.,  2000).  These  cytokines,  which  are  produced  by  TFH  cells  located  in  the 
germinal  centre  (Dullaers  et  al.,  2009),  bind  to  the  respective  receptors,  IL-21 
receptor (IL-21R) and TGF-β receptor (TβR) and provide the signals required for 
growth  and  differentiation  of  activated  B  cells  into  IgA  producing  plasma  cells 
(Kehrl et al., 1986; Parrish-Novak et al., 2000). 
Switching between isotypes occurs at the genetic level, where genes coding for the 
heavy chain (CH) of BCRs are rearranged rather than altered, as is the case for SHM 
(Xu  et  al.,  2012).  As  gene  deletion  is  involved,  CSR  relies  on  cell  division  for 
switching  between  isotypes,  where  each  round  of  cell  division  results  in  the 
production a different isotype (Hodgkin et al., 1996; Deenick et al., 1999). 
1.6.4  Plasmablasts Migrate to Effector Sites and Terminally Differentiate into 
Plasma Cells  
Most activated B cells emerge from GCs as PBs, which are the precursors of plasma 
cells, although some emerge as memory B cells (Zotos and Tarlinton, 2012). PBs 
produce  antibody  isotypes  identical  to  that  of BCRs  expressed  on  their  surfaces. 
However, the amount of antibodies produced by PBs is comparably less than that 
produced by plasma cells (Tarlinton et al., 2008). Regardless, PBs express BCRs and 
thus retain the ability to bind antigens, present antigens and undergo proliferation, Chapter 1.                                                                                                    Literature Review and Introduction 
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which terminally differentiated plasma cells are no longer capable of (Chan et al., 
2009).   
PBs emerging from GCs migrate (or home) to effector sites where they terminally 
differentiate into plasma cells (Chan et al., 2009). Homing to the effector sites is 
mediated by the expression of surface proteins that include integrins and chemokine 
receptors (Warnock et al., 1998).  
1.7  IgA is Crucial for Respiratory Mucosal Immunity 
IgA  is  the  predominant  antibody  isotype  found  at  the  respiratory  mucosa  and  is 
produced by mucosal plasma cells residing in the lamina propria. The structural and 
functional features of IgA render it efficient for preventing infections and allergic 
responses  (Karlsson  et  al.,  2010).  As  such,  IgA  plays  a  crucial  role  in  frontline 
mucosal immune defence.  
1.7.1  Physical and Structural Properties of IgA 
IgA monomers (160 kDa) have a distinct y-shape structure, which is attributed to the 
spatial arrangement of heavy and light polypeptide chains that make up the molecule 
(Silverton et al., 1977). Each monomer is comprised of two identical heavy (both α) 
and two light chains (κ or λ). Disulphide bonds link each light chain with a heavy 
chain and also hold the two heavy chains together (Figure 1.7). An 18 amino acid 
long polypeptide known as the α tail-piece (αtp) extends from the C-terminus of each 
heavy chain (Yoo et al., 1999).  
Two distinct functional regions, the fragment antigen-binding (Fab) and fragment 
crystallisable (Fc) regions, allow IgA molecules to perform as effector molecules 
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variable antigen binding site (VL and VH) that is used for pathogen recognition and 
binding. The constant heavy chain (CH) of the Fc region mediates interactions with 
effector molecules and receptors specific for IgA known as FcαRs. The Fab and Fc 
regions  are  held  together  by  the  hinge  region,  which  confers  overall  structural 
flexibility and facilitates pathogen binding.  
 
Figure 1.7 Structure of IgA. IgA is comprised of two heavy chains (CH) and two light chains (CL) 
that are held together by disulphide bonds. The α tail-piece (αtp) extends from the C-terminus of each 
chain. IgA has two functional regions, the fragment antigen-binding (Fab) and fragment crystallisable 
(Fc).  
 
1.7.2  Secretion of Dimeric IgA onto the Respiratory Mucosa 
IgA secreted at respiratory mucosal surfaces is synthesised primarily as a dimer by 
mucosal plasma cells (Figure 1.8). Dimeric IgA (335 kDa) accounts for 80% of total 
secreted IgA (DelaCroix et al., 1982; reviewed by Pilette et al., 2001). Trimeric and 
tetrameric forms of IgA are also secreted at mucosal surfaces but in minute quantities 
and are, in general, of lesser immunological significance (Vaerman et al., 1995).  
Assembly of IgA dimers occurs within mucosal plasma cells, before secretion into 
the  airways.  The  process  involves  the  tail-to-tail  linking  of  two  IgA  monomers, 
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the tail-piece (reviewed by Johansen et al., 2000). Joining chains (J chains) produced 
in concomitance with dimeric IgA by mucosal plasma cells are also involved in the 
dimerisation  process  (Halpern  and  Koshland,  1970).  They  are  exclusively 
incorporated into dimeric IgA, bridging only one of the two adjoining tail pieces via 
disulphide bonds (Garcia-Pardo et  al.,  1981).  The physical  association between J 
chains  and  dimeric  IgA  is  essential  for  proper  subsequent  secretion  at  mucosal 
surfaces (Hendrickson et al., 1996; Vaerman et al., 1998).  
 
 
Figure 1.8 Structure of dimeric IgA. Two monomeric IgA are linked by their αtps to form dimeric 
IgA. The joining chain (J chain) is exclusively incorporated into dimeric IgA, bridging only one of the 
two adjoining αtps via disulphide bonds.  
 
Secretion of dimeric IgA occurs via a transport process known as transcytosis, where 
dimeric IgA is released into the lamina propria by mucosal plasma cells, before being 
transported across the mucosal epithelium and released onto the respiratory mucosal 
surface  (Figure  1.9).  Transmembrane  poly-immunoglobulin  receptors  (pIgRs)  on 
their  basolateral  surface  of  mucosal  epithelial  cells  bind  dimeric  IgA,  thereby 
triggering  endocytosis  of  this  IgA-receptor  complex.  The  internalised  complex  is 
transported in a vesicle to the apical surface and subsequently released as secretory 
IgA (SIgA) by enzymatic cleavage of the pIgR. SIgA differs from dimeric IgA in 
that  it  is  attached  to  a  secretory  component  (SC),  the  extracellular  fragment 
(ectodomain of pIgR) formed following enzymatic cleavage (Song et al., 1994).  Chapter 1.                                                                                                    Literature Review and Introduction 
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Figure 1.9 Release of secretory IgA (SIgA) into the airway. Dimeric IgA is produced by plasma 
cells situated in the lamina propria of the respiratory mucosal. Transport of dimeric IgA across the 
respiratory epithelia is mediated by pIgR expressed on the basolateral surface of mucosal epithelial 
cells. SIgA is released by the enzymatic cleavage of pIgR, with the extracellular fragment of pIgR 
remaining attached to SIgA (adapted from Johansen et al., 2000). 
 
1.7.3  Mechanisms of Pathogen Removal by Dimeric and Secretory IgA at the 
Respiratory Mucosa 
The primary immune effector function of dimeric and secretory IgA is to remove 
pathogens within the internal and external environments of the respiratory tract (Yan 
et al., 2002). Pathogen removal mediated by both forms of IgA occurs via three 
different mechanisms: exclusion, neutralisation and secretion.  
1.7.3.1 Immune Exclusion 
Pathogens  removal  by  immune  exclusion  with  SIgA  occurs  within  the  external 
environment (i.e. respiratory mucosal surface). SIgA on respiratory mucosal surfaces 
binds pathogens, thus preventing pathogen-host cell interactions that are essential for 
establishing infections. SIgA binds efficiently to pathogens, owing to an increase in 
the number of antigen binding sites per antibody molecule following dimerisation 
(Renegar et al., 1998). Pathogenic products such as toxins, which exert their effect by 
interacting with host cells, are also removed by immune exclusion SIgA (Stubbe et 
al., 2000).  Chapter 1.                                                                                                    Literature Review and Introduction 
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1.7.3.2 Intraepithelial Neutralisation 
Intraepithelial neutralisation can be regarded as the immune exclusion of pathogens 
at an intracellular level. Dimeric IgA enroute to the apical surface of epithelial cells 
during transcytosis binds to pathogens (especially viruses) that have penetrated the 
epithelial  barrier,  limiting  their  ability  to  replicate  within  host  cells  and  the 
subsequent infection of other cells (Mazanec et al., 1992; Yan et al., 2002; Wright et 
al., 2006).  
1.7.3.3 Excretion of Immune Complexes  
Pathogens that have managed to breach the respiratory mucosa to the level of the 
lamina propria are removed by excretion. Dimeric IgA released by mucosal plasma 
cells in the lamina propria bind to toxins and invading pathogens present to form 
immune complexes. These immune complexes are then excreted via the same pIgR 
mediated transport mechanism that secretes SIgA from mucosal epithelial surfaces, 
keeping the internal environment sterile (Kaetzel et al., 1991; Yan et al., 2002).  
1.8  Conditioning of B cells for Immunoglobulin A Production  
The biology of many different cell types can be studied in vitro (Abbott, 2003). In 
immunology,  different  immune  cell  types  have  been  cultured  under  specified 
conditions in vitro to replicate certain aspects of their biology in vivo. This allows the 
complex  biology  of  immune  cells  to  be  studied  in  detail  and,  with  greater  ease, 
providing deeper insights into the functions of these cells in vivo (Miller et al., 1992; 
Hartmann et al., 2000).  
Class-switching is a major aspect of B cell biology that is studied in vitro, where 
naïve  B  cells  are  commonly  cultured  in  media  containing  various  cytokines  and 
stimulatory  signals.  In  light  of  the  significant  role  that  IgA  plays  in  mucosal Chapter 1.                                                                                                    Literature Review and Introduction 
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protection, IgA class-switching by B cells is intensely studied (McIntyre et al., 1995; 
Bryant et al., 2007; Jiang et al., 2007; Seo et al., 2009). While these studies are often 
concerned  with  the  underlying  mechanisms  involved,  “conditioning”  (a  term 
proposed by this project) however focuses on the application of the methods and 
outcomes generated by these studies.  
A recent study conducted in vitro with human B cells to determine factors involved 
in IgA class-switching successfully generated mucosal homing IgA PBs (Dullaers et 
al., 2009). The authors cultured naïve human B cells with anti-IgM, anti-CD40, IL-2, 
CpG, IL-21 and TGF-β1 in vitro. These reagents represent the signals that naïve B 
cells encounter during activation and class-switching in GCs in vivo. Anti-IgM was 
used to initial activation by antigen recognition. Anti-CD40 and IL-2 was used to 
provide co-stimulation that is required for TD activation of naïve B cells. CpG, on 
the other hand, was used to replicate TI activation of naïve B cells (Gururajan et al., 
2007). To provide signals that direct IgA class-switching in vivo, IL-21 and TGF-β1 
was used.  
Culture of naïve B cells with the signals described above resulted in the generation of 
mucosal homing IgA PBs. These PBs were found to express CCR10, which directs 
homing to various mucosal sites. The major implication suggested by the authors was 
a  better  understanding  of  the  factors  driving  IgA  mucosal  responses.  From  a 
conditioning  perspective,  the  authors  have  described  a  methodology  for  which 
mucosal homing plasmablasts can be generated in vitro and, possibly  be used in 
therapeutic  applications.  Another  possible  application  would  be  the  in  vitro 
generation of IgA in vast quantities, which can then be harvested and administered 
for therapeutic purposes.  Chapter 2.                                                                                                                                Aims and Hypothesis 
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Chapter 2.   Aims and Hypothesis 
The successful in vitro generation of mucosal homing IgA PBs from human naïve B 
cells by Dullaers et al. (2009) has revealed that IL-21 and TGF-β1, in addition to 
anti-IgM, anti-CD40, IL-2 and CpG, are essential for generating strong mucosal IgA 
responses (Dullaers et al., 2009). Interestingly, these mucosal homing IgA PBs were 
found  to  express  a  chemokine  receptor  that  directs  non-site  specific  homing  to 
mucosal surfaces (Lazarus et al., 2003; Morteau et al., 2008). These findings have 
important  implications  in  light  of  mucosal  vaccine  design,  indicating  that  new 
vaccine candidates should aim to enhance IL-21 and TGF-β1 mediated responses in 
vivo (Dullaers et al., 2009).  
This project approached these findings from a different perspective, focusing more 
on the therapeutic applications for these homing IgA PBs, especially with regards to 
respiratory diseases. By conditioning autologous naïve B cells in vitro, the generated 
mucosal  homing  IgA  PBs  can  later  be  re-introduced  in  vivo  to  enhance  antigen 
specific humoral responses against pathogens and allergens at the respiratory mucosa. 
With this  potential clinical  application as  the  ultimate goal,  an intermediate goal 
would  be  to  assess  the  therapeutic  potential  of  these  cells  in  mouse  models  of 
respiratory diseases. This would show proof-of-concept, a necessary and crucial step 
before translation into a clinical setting.  
The immediate goal of this project was to determine if the findings of Dullaers, Li et 
al. (2009) could be applied to a murine model, as the effect of IgM, anti-CD40, IL-2, 
CpG, IL-21 and TGF-β1 on murine naive B cells has not been reported previously. 
Nevertheless, a published finding that IgA production increased when murine B cells 
were cultured in vitro with  IL-21 and TGF-β1 (Seo et al., 2009), provides some Chapter 2.                                                                                                                                Aims and Hypothesis 
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justification for this study. As such, the specific aims of the project were focused on 
demonstrating aspects that were deemed to be key indicators of successful naïve B 
cell conditioning. Thus, the aims of the project were: 
1.  To  establish  a  methodology  for  rapid  purification  of  naïve  B  cells  from 
mouse spleen using magnetic bead isolation approaches. 
 
2.  Demonstrate  in  vitro  proliferation  of  murine  naïve  B  cells  to  a  sufficient 
extent to allow IgA class-switching following in vitro conditioning with anti-
IgM, anti-CD40, CpG, IL-2, IL-21 and TGF-β1. 
 
3.  Quantify  IgA  production  following  in  vitro  B  cell  conditioning  to  obtain 
preliminary evidence for the successful generation of IgA PBs.   Chapter 3.                                                                                                                           Materials and Methods 
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Chapter 3.  Materials and Methods 
Animals acquired and the experimental procedures performed for this project were 
approved by  the Murdoch University Research  Ethics  Office (Approval Number: 
R2467/12).  All  reagents  used  were  prepared  according  to  the  manufacturer’s 
specifications,  unless  indicated  otherwise.  Additional  details  (manufacturer  and 
catalogue number) of the reagents are listed in Appendix A. 
3.1  Animal Agistment   
Pathogen-free female BALB/c mice within the age range of 8 to 12 weeks  were 
obtained from the Animal Resources Centre (ARC), Canning Vale, WA. Mice were 
usually sacrificed immediately upon receipt for experiments. When necessary, mice 
were housed for up to a maximum of 4 weeks at the Murdoch University Animal 
House (Murdoch, WA) in an ambient temperature of 21°C with a 12h:12h light:dark 
cycle. Food and water were available ad libitum and tissue paper was provided for 
environmental  enrichment.  During  the  holding  period,  mice  were  monitored  for 
behavioural  and  physical  indicators  of  their  health  status,  such  as  self-grooming, 
eating  and  drinking  patterns,  startle  reflex  and  communal  behaviour  (refer  to 
Appendix B - Animal Monitoring Sheet).  
3.2  Euthanasia and Tissue Collection 
Mice were euthanised for the collection of spleens. Prior to euthanasia by cervical 
dislocation, mice were anaesthetised by inhalation of 3% halothane in a gas chamber. 
Charging of the gas chamber was done initially with 5% halothane and subsequently 
lowered to 3% before introducing mice into the chamber.  Chapter 3.                                                                                                                           Materials and Methods 
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Spleens from two mice were collected aseptically and pooled to minimise biological 
variability  between  individual  mice.  Mouse  abdomens  were  swabbed  with  70% 
ethanol (EtOH) before dissection with UV-sterilised scissors and tweezers. Collected 
spleens  were  stored  in  filter  sterilised  fluorescent  activated  cell  sorting  (FACS) 
buffer containing 5% heat inactivated fetal bovine serum in Dulbecco’s phosphate 
buffered saline (5% HI FBS in DPBS) and kept on ice until use for cell extraction.  
3.3  Naïve B cell Extraction and Enrichment 
Magnetic depletion was used to isolate naïve B cells from the mixed population of 
cells present in mouse spleens. A pure population of naïve B cells was necessary for 
obtaining results that were representative of these cells.  
3.3.1  Preparation of Splenocyte Suspension  
Splenocytes  comprising  B  cells  were  extracted  from  collected  spleens  as  a  cell 
suspension. Each spleen was injected at opposite ends with 0.5 mL of FACS buffer 
using a 3 mL syringe and a 23 gauge needle (Figure 3.1A). Cells dislodged by the 
injected  buffer  were  gently  teased  out  through  the  holes  made  during  injection 
(Figure 3.1B). Clumps of cells were mechanically disaggregated by syringing with 
the same needle (Figure 3.1C) and filtering through a cotton wool column (Figure 
3.1D). After spinning of the initial cell suspension at 520 g for 7 min in a refrigerated 
(4°C) Beckman-Coulter centrifuge, the supernatant was removed by aspiration. Red 
blood cells in the pellet were lysed by resuspension in 5 mL 1X Flow Cytometry 
Mouse Lyse Buffer for 10 min at room temperature. Cold FACS buffer was added in 
excess  to  stop  the  lysis  reaction  and  lysates  were  removed  by  aspiration  of  the 
supernatant following centrifugation (same conditions as before). The resultant pellet 
was  resuspended  in  4  mL  of  FACS  buffer  to  yield  a  single  cell  suspension  of Chapter 3.                                                                                                                           Materials and Methods 
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splenocytes. The number of viable splenocytes present in the suspension was counted 
manually with an improved Neubauer haemocytometer, at a 1 in 10 dilution of the 
cell suspension with 0.4% Trypan Blue staining solution. After counting ≥ 100 viable 
(unstained)  cells  in  the  middle  square,  the  final  concentration  of  viable  cells  in 
cells/mL was determined using the following equation:  
                   (         ⁄ )   
               
                                            
 
Figure 3.1 Extraction procedure of splenocytes from mouse spleen. A) FACS buffer (DPBS with 5% 
FBS) was injected into the distal ends (filled arrows) of each spleen. B) Splenocytes were teased out 
of  the  spleen  through  holes  made  during  FACS  buffer  injection  by  scraping  with  a  bent  needle 
(direction indicated with a hollow arrow). C) Cell clumps were disaggregated by syringing. D) Cells 
were filtered through a cotton wool column to remove fine clumps of cells.  
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3.3.2  Enrichment of Splenocyte Suspension for Naïve B Cells 
The proportion of naïve B cells in splenocyte suspensions was enhanced by magnetic 
depletion  of  other  cells  with  the  use  of  a  commercially  purchased  Mouse  B 
Lymphocyte  Enrichment  Set.  Modifications  were  made  to  the  manufacturer’s 
protocol to accommodate the removal of CD27 expressing memory B cells.  
Briefly,  1  ×  10
8  splenocytes  were  incubated  in  500  µL  of  Biotin  Mouse  B 
Lymphocyte Enrichment Cocktail and 100 µL of biotin hamster anti-mouse CD27 at 
4°C for 15 min. Unbound antibodies from the cocktail were removed by a standard 
wash step that involved adding excess volumes of FACS buffer, centrifugation under 
conditions described above and aspiration of the supernatant. The cell pellet was 
resuspended  in  600  µL  of  streptavidin  particles  from  the  enrichment  kit  and 
incubated at 4°C for 30 min. FACS buffer was added to a final volume of 2 mL to 
yield a cell concentration of 5 x 10
8 cells/mL. Negative selection for naïve B cells 
was performed by standing 1 mL aliquots of the cell suspension in sterile 12 x 75 
mm round bottom tubes on a cell separation magnet for 8 min (Figure 3.2A). Naive 
B  cells  present  in  the  supernatant  were  collected  while  undesired  cells  (positive 
selection) remained in the pellet (Figure 3.2B).  
Naïve  B  cell  recovery  was  optimised  by  resuspending  the  pellets,  standing 
suspension aliquots in tubes on the cell separation magnet for another 8 min and 
collecting the supernatant. The process was repeated twice and collected supernatants 
were pooled to obtain an enriched fraction, which was put on the cell separation 
magnet one last time for 8 min to obtain a final suspension (twice enriched fraction). 
A flow diagram of the separation procedure is illustrated in Figure 3.3.  
The number of viable cells present in the twice enriched fraction was determined 
using the same cell counting method described previously, but at a 1 in 5 dilution of Chapter 3.                                                                                                                           Materials and Methods 
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the enriched cell suspension. The purity of naïve B cells before and after enrichment 
was determined by flow cytometry (Section 3.5.3). 
 
Figure 3.2 Isolation of naïve B cells by magnetic depletion. A) Tubes containing cells that have 
been incubated with streptavidin particles were placed on the cell separation magnet for 8 min. B) 
Naïve B cells that were not bound by the magnetic streptavidin particles remained in the supernatant 
and were collected as an enriched fraction.  
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Figure 3.3 Naïve B cell isolation protocol. Cells were washed after antibody incubation by adding excess volumes of FACS buffer, centrifuging at 1800 RPM for 7 min and 
aspiration of the supernatant. After standing on the cell separation for 8 min, supernatants containing naïve B cells were collected and pellets were resuspended by repeated 
pipetting with 1 mL FACS buffer. Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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3.4  Naïve B Cell Labelling and In vitro Conditioning 
Isolated naïve  B  cells  were labelled with  the  fluorescent dye, carboxyfluorescein 
succinimidyl ester (CFSE), to allow for the tracking of cell division. These labelled 
cells were then cultured in different conditioning mixtures. 
3.4.1  CFSE Labelling for Tracking Cell Division 
Cells  from  the  twice  enriched  suspension  were  labelled  with  5  µM  CFSE 
(determined by titration, Section 3.5.2) from a CellTrace CFSE Cell Proliferation Kit. 
Briefly, 30 µL of 5 mM stock CFSE solution was added to 30 ml of cell suspension 
(in FACS buffer) containing 3 x 10
7 cells. Following incubation at 37°C for 10 min, 
5 volumes of cold FACS buffer was added and kept on ice for 5 min to quench the 
staining.  Labelled  cells  were  washed  thrice  with  FACS  buffer  to  remove  excess 
CFSE. In preparation for conditioning, the pellet was resuspended in complete media 
containing RMPI 1640 supplemented with 10% HI FBS, 50 µM 2-mercaptoethanol 
(2-ME) and 2 mM L-glutamine, at a concentration of 2 x 10
5 cells/100 µL. 
3.4.2  In vitro B Cell Conditioning 
In  separate  experiments,  CFSE  labelled  naïve  B  cells  were  cultured  over  two 
different time courses: 1) 1, 3, 6, 9 and 12 days and 2) 1, 3, 5, and 7 days. The shorter 
time  course  was  used  in  later  experiments  after  initial  experimentation  with  the 
longer time course revealed poor cell viability at later time points (Section 5.3).  
CFSE  labelled  naïve  B  cells  were  conditioned  with  four  different  mixtures  of 
conditioning  reagents,  each  prepared  in  complete  media  (Table  3.1).  The 
concentration used for each conditioning reagent was determined after consulting 
published literature. Labelled cells were also cultured in complete media containing Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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1 µg/mL LPS for comparison of proliferative responses. The concentration used was 
determined after a trial conditioning experiment revealed no differences in viable cell 
numbers  between  1  and  10  µg/mL  LPS  (Section  4.5).  Cells  maintained  only  in 
complete media served as negative (unstimulated) controls.  
 







1  2  3  4 
Anti-IgM  5 µg/mL   Ozaki, Spolski et al. 2004     
Anti-CD40  5 µg/mL   Pellegrini, Guiñazú et al. 2007     
IL-2  40 U/mL  Zeng, Spolski et al. 2007     
Type B CpG  10 µg/mL   Chu, Enghard et al. 2007     





TGF-β1  0.2 ng/mL  Seo, Youn et al. 2009 
     
 
Labelled  naïve  B  cells  were  cultured  in  96-well  tissue-culture  round  bottom 
microplates (BD Biosciences, USA; #353077). One microplate was used for each 
time point within the time course, minimising contamination risks and easing sample 
collection. In total, four microplates were prepared for the shorter time course and 
five for the longer time course.  
Six different culture conditions were set up on each microplate. Each condition was 
carried out in quadruplicates (1 well/replicate) and a final cell concentration of 2 x 
10
5 cells/200 µL/well was used.  All microplates were incubated in a humidified 
37°C incubator (Shanghai Lishen Scientific Equipment Co., Ltd., China; Heal Force 
HF90) containing 5% CO2 for the respective culture duration.  
Naïve B cells (2 x 10
5 cells/100 µL/well) were incubated in anti-IgM coated wells at 
37°C for 2 hr to allow for cross-linking of BCRs expressed on naïve cells and hence, 
initial stimulation. Anti-IgM was coated onto the wells of microplates a day prior to 
conditioning. An anti-IgM solution of 100 µL (prepared in DPBS) was delivered into Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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each  well  and  incubated  overnight  at  4°C.  Excess  antibody  was  removed  after 
coating by flicking and microplates were blotted on dry paper towels. 
The  remaining  reagents  for  each  conditioning  mixture  were  added  into  their 
respective wells as a master mix at 100 µL/well, bringing the final volume in each 
well up to 200 µL. Owing to a 1:2 dilution, the master mix for each condition was 
prepared in complete media at twice the final working concentration. As IL-21 and 
TGF-β1 were used at low concentrations (ng/mL), an intermediate 1 in 100 dilution 
step was performed to allow for accurate micro-pipetting. 
LPS and negative control wells were set up in non-coated wells after the initial 2 hr 
incubation. Cells were introduced into each well at 2 x 10
5 cells/100 µL/well and 100 
µL of 2 µg/mL LPS was added next to obtain a final working concentration of 1 
µg/ml. A 100 µL volume of complete media was added to the negative control wells.  
3.4.3  Sample Collection and Storage 
Cells and culture supernatants were collected at each time point for all six culture 
conditions.  Sample  collections  were  performed  on  ice  to  minimise  protein 
degradation and cell death. Contents from the respective wells for each condition 
were pooled, to average the variability amongst replicates, into sterile 12 x 75 mm 
round bottom tubes. Culture supernatants of 600 µL volumes were collected from 
each tube after centrifuging at 520 g and 4°C for 7 min. Collected supernatants were 
stored in microtubes at -20°C for subsequent IgA quantification by ELISA (Section 
3.6). Cells free of culture media were retrieved by resuspending pellets in excess 
FACS  buffer,  centrifugation  as  described  in  Section  3.3.1  and  aspiration  of  the 
supernatant.  Cells  were  fluorescently  labelled  and  analysed  immediately  by  flow Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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cytometry  after  retrieval  (Section  3.5.3).  The  collection  procedure  is  depicted  in 
Figure 3.4. 
 
Figure 3.4 Cell and culture supernatant collection protocol. Cells and culture supernatant from 
each condition were collected at all four time points and analysed respectively by flow cytometry and 
enzyme-linked immunosorbent assay (ELISA). Quadruplicate wells were pooled during collection. 
Cells were stained and analysed immediately, while culture supernatants were stored at -20°C until 
subsequent analysis by ELISA.  
 
3.5  Flow Cytometric Analysis of Labelled Cells 
Cells samples collected before and after enrichment, together with those collected at 
various time points after conditioning, were labelled with several fluorescent markers 
and analysed by flow cytometry.  
3.5.1  Instrumentation and Analysis Software 
Cells were analysed shortly after labelling with one of the two BD FACSCanto II 
flow  cytometers  (BD  Biosciences,  USA)  available  at  Murdoch  University  or  the 
Centre  for  Microscopy,  Characterisation  and  Analysis  (CMCA),  University  of 
Western Australia. Identical excitation wavelengths and optical filters (i.e. emission 
band pass (BP) filters) were used on both instruments for data acquisition (Table 3.2). 
Data on the fluorescence intensity and forward and side scatter of 100,000 cells was 
collected with BD FACSDiva software (BD Biosciences, USA; PC version 6.1.2). Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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The data collected was analysed using FlowJo software (Tree Star Inc., USA; PC 
version 7.6.5).  
 
Table 3.2 Excitation lasers and optical filters equipped on the BD FACSCanto II.  
Instrument: BD FACSCanto II       
Laser lines 
488 nm  
(blue) 




633 nm (red) 
Optical 
filters 
585/42 BP  530/30 BP  660/20 BP  780/60 BP 
Colour  Yellow/Orange  Green  Red  Far Red 
3.5.2  Optimisation of FACS Staining by Titration 
To determine optimal staining concentrations, all staining reagents were titrated on 
splenocyte (pre-enriched) suspensions. Cells were kept on ice (≤ 4°C) at all times 
during staining and flow analysis to avoid capping (redistribution and internalisation 
of  surface  molecules),  which  would  interfere  with  fluorescence  intensity 
measurements (Loor et al., 1972). Stained samples were stored protected from light 
to prevent photobleaching.  
3.5.2.1 Fluorochrome-conjugated Monoclonal Antibodies  
Serial dilutions (1:100, 1:200, 1:400 and 1:800) of Phycoerythrin (PE)-CD19 MAb 
were prepared in FACS buffer. Cells (1 x 10
6) were incubated in 100 µL of each 
dilution for 20 min. Labelled cells were washed once as described in Section 3.3.1 to 
remove  excess  antibody.  Unless  otherwise  mentioned,  all  labelled  cells  were 
resuspended in 500 µL FACS buffer after the final wash for subsequent flow analysis.  
3.5.2.2 Biotin-conjugated Monoclonal Antibody  
Serial  dilutions  of  1:100,  1:200,  1:400  and  1:800  were  prepared  for  the  biotin 
conjugated CD27 MAb (Bio-CD27), while dilutions of 1:250, 1:500, 1:1000 and 
1:2000 were prepared for allophycocyanin conjugated streptavidin (APC-SA). Cells Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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(1x10
6) were stained in two separate 20 min incubation steps, the first with dilutions 
of  biotin  hamster  anti-mouse  CD27  and  the  second  with  dilutions  APC-SA, 
generating 16 possible staining combinations (Table 3.3). Cells were washed after 
each incubation step to remove excess reagents.  
Table 3.3 Titration of biotin-CD27 and APC-streptavidin. Serial dilutions were titrated in a single 
experiment, using a matrix that generates 16 possible combinations between the two reagents. 
 1st Incubation: Bio-CD27 
2nd Incubation: APC-SA 
1:250  1:500  1:1000  1:2000 
1:100  Tube 1  Tube 2  Tube 3  Tube 4 
1:200  Tube 5  Tube 6  Tube 7  Tube 8 
1:400  Tube 9  Tube 10  Tube 11  Tube 12 
1:800  Tube 13  Tube 14  Tube 15  Tube 16 
 
3.5.2.3 LIVE/DEAD Near-IR Fixable Cell Stain 
A stock solution of the dye was prepared by reconstituting the lyophilised contents of 
a single vial with 50 µL of anhydrous DMSO. Stock solution volumes of 0.5 µL, 1 
µL and 1.5 µL were delivered into separate tubes containing 1 x 10
6 cells in 1 mL of 
FACS buffer, half of which were rendered non-viable by snap freezing (Kandil et al., 
2005). Cells were incubated with the dye for 30 min. Excess dye remaining after 
staining was removed by performing three consecutive washes.  
3.5.2.4 CellTrace CFSE Cell Proliferation Stain 
A  5  mM  stock  solution  of  CellTrace  CFSE  was  prepared  by  dissolving  the 
lyophilised  contents  of  a  single  vial  in  18  µL  of  anhydrous  DMSO.  Cells  were 
labelled as described in Section 3.4.1 with either 5 µM, 10 µM, 15 µM or 25 µM 
CFSE.  Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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3.5.3  Staining Panels  
Two  staining  panels,  an  enrichment  panel  and  a  proliferation  panel,  were  used 
respectively to determine naïve B cell purity and the proliferation of specific B cell 
subpopulations (Table 3.4).  
 
Table 3.4 Fluorescent reagents used in each staining panel and the respective emission filters 
used for detection. 
Panel  Fluorescent Reagent  Clone  Emission Filter 
Enrichment 
PE-CD19 MAb  6D5  585/42 BP 
APC-CD27 MAb  LG3.A10  660/20 BP 
LIVE/DEAD Fixable Near-IR Cell Stain  -  780/60 BP 
Proliferation 
LIVE/DEAD Fixable Near-IR Cell Stain  -  780/60 BP 
CellTrace CFSE Cell Proliferation  -  530/30 BP 
3.5.3.1 Enrichment Staining 
Non-specific binding between fluorochrome-conjugated MAbs and low-affinity Fc 
receptors  expressed  on  the  surface  of  cells  was  blocked  to  prevent  increased 
background staining. 2 µL Mouse BD Fc Block (purified rat anti-mouse CD16/32) 
was added to 1 x 10
6 cells in 100 µL FACS buffer and incubated for 5 min. Cells 
were washed and used immediately for staining. 
In separate staining tubes, 1 x 10
6 cells from pre- and post-enriched suspensions were 
incubated with 100 µL of a master mix containing 0.5 µg/mL PE-CD19 MAb and 
2.5 µg/mL Bio-CD27 MAb for 20 min. Cells from each tube were washed and then 
incubated with 100 µL of 0.8 µg/mL APC-SA for 20 min. After a second wash, cells 
were resuspended in 1 mL of FACS buffer and incubated with 0.5 µL of dye solution 
from the LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit for 30 min. Excess dye 
was removed by performing three consecutive washes. Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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3.5.3.2 Proliferation Staining  
Cells were collected as  described in Section 3.4, resuspended in 1 mL  of FACS 
buffer and incubated with 0.5 µL LIVE/DEAD Fixable Near-IR Dead Cell Stain for 
30 min. Three consecutive washes were performed to remove excess dye.  
3.5.4  Controls and Compensation 
Unstained  controls,  single  stained  controls  and  fluorescence  minus  one  (FMO) 
controls relevant to each panel were analysed together with their respective panels. 
Single stained controls, each containing cells stained with a different probe from the 
panel,  were  analysed first  to compensate  for spillover  (spectral  overlap)  between 
detection  channels.  After  gating  on  the  positive  and  negative  staining  cell 
populations  for  each  stain,  compensation  matrices  were  generated  by  the 
compensation tool BD FACSDiva and applied onto FMO controls and samples.  
FMO controls, each comprised of every stain in the panel other than the one being 
controlled for, were prepared and analysed to help with the determination of gating 
boundaries. Three FMO controls were analysed for the enrichment panel, one for 
each of the stains. None were required for the proliferation panel given the number of 
stains used. Instead, undivided controls (i.e. negative controls in Section 6.4.2) were 
analysed to aid with the analysis of cell division.  
3.5.5  Early Cell Gating Strategy  
Gates set early in the analysis were identical for both panels and used consistently for 
all sample analyses. Cells were discriminated from cellular debris by gating broadly 
on  forward  scatter  (FSC)  and  side  scatter  (SSC)  characteristics  (Figure  3.5A). 
Aggregates of cells were excluded with a doublet discriminator gate (Figure 3.5B).  
Non-viable  lymphocytes  were  excluded  by  gating  on  viable  cells  that  stained Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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negatively with the viability dye (Figure 3.5C). Boundaries used for gating on viable 
cells were determined using a FMO control for the viability dye. 
 
Figure 3.5 Early cell gating strategy. Cellular debris, cell aggregates and dead cells were excluded 
from analysis by sequential gating around cells, single cells and viable cells on bivariate dot plots of A) 
forward scatter area (FSC-A) versus  side scatter area (SSC-A), B) FSC-A  versus  forward scatter 
height (FSC-H) and C) Near-IR fluorescence intensity versus SSC-A.  
 
3.6  IgA Enzyme-linked Immunosorbent Assay  
Soluble IgA in the culture supernatant was quantified by sandwich enzyme-linked 
immunosorbent  assay  (ELISA)  using  a  Mouse  IgA  Ready-SET-Go!  ELISA  kit. 
Sandwich ELISAs work in general by using specific capture and detection antibody 
pairs to form conjugates where target antigens are “sandwiched” in between. 
3.6.1  ELISA Optimisation and Controls 
Refinements to the manufacturer’s protocol were made to increase the absorbance 
range obtained for serially diluted mouse IgA standards (Section 4.3). The incubation 
temperature, except for coating and blocking, was raised from room temperature to 
37°C  and  colour  development  was  extended  from  15  min  to  30  min  or  45  min. 
Culture  supernatants  were  not  analysed  during  assay  optimisation  to  conserve 
samples and reagents. Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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Blank and negative controls were included in every assay. The former was included 
to correct for background absorbance of the assay buffer used as a diluent. Wells 
containing  only  culture  media  were  used  as  negative  controls.  Isotype  controls 
containing purified mouse IgG1 MAb was included in the final round of optimisation 
to test for IgA specificity.  
3.6.2  Coating and Blocking of Microplates  
Flat  bottom  96-well  high  binding  microplates  were  coated  (100  µL/well)  with  a 
1:250 dilution of purified anti-mouse IgA MAb (capture antibody) that was prepared 
in a coating buffer. Plates were sealed and incubated overnight at 4°C. Unbound 
capture  antibodies  were  removed  by  two  wash  cycles  on  a  microplate  washer 
(Biochrom Ltd., UK; Asys Atlantis) with sodium azide free wash buffer (1x PBS 
with  0.05%  Tween-20).  Each  wash  cycle  involved  the  addition  of  400  µL  wash 
buffer into each well, which was allowed to soak for 1 min before removal through 
aspiration. Microplates were blotted face down on dry paper towels after the last 
wash cycle. Non-specific binding sites in each well were blocked by incubation with 
blocking buffer (250 µL/well) at room temperature for 2 hr. Blocked plates were 
washed twice afterwards. 
3.6.3  Standard, Sample and Control Incubation 
In  duplicates  (100  µL/well/replicate),  negative  controls,  blank  controls,  isotype 
controls, standards and culture supernatants were incubated in coated and blocked 
wells  at  37°C  for  2  hr.  A  2-fold  serial  dilution  of  the  reconstituted  mouse  IgA 
standard (50 ng/mL) with assay buffer was performed to obtain diluted standards 
ranging from 0.39 to 25 ng/mL.  Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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Sample culture supernatants collected after 1, 3, 6, 9 and 12 days from cells cultured 
under condition 4 were analysed only in the initial assay prior to optimisation. In 
anticipation of IgA production, culture supernatants collected from condition 4 (see 
Table 1) of the longer experimental time course were analysed. Samples were plated 
neat and at 1:2, 1:10 and 1:100 dilutions with assay buffer. 
Isotype  controls  of  purified  mouse  anti-bovine  IgG1  (isotype  IgG1),  at 
concentrations matching that of the mouse IgA standards, were analysed. Starting at 
a  1:2000  dilution  of  the  neat  IgG1  MAb  (10-50  µg/mL),  separate  serial  2-fold 
dilutions  with  culture  media  and  assay  buffer  were  performed.  The  highest  and 
lowest possible concentration generated by serial dilution was 25 ng/mL and 0.08 
ng/mL respectively. 
3.6.4  IgA Detection and Colour Development  
Microplates  were  put  through  four  wash  cycles  before  100  µL  of  horse  radish 
peroxidase  (HRP)-conjugated  anti-mouse  IgA  MAb  (1:250  dilution  of  capture 
antibody prepared in assay buffer) was added to each well and incubated at 37°C for 
1 hr. After another four wash cycles, 100 µL of neat tetramethylbenzidine (TMB) 
substrate solution was added to each well incubated at 37°C for 30 min for colour 
development. A stop solution of 1M H2SO4 at 100 µL/well was added after 30 min to 
stop colour development. 
3.6.5  Absorbance Measurement and Data Analysis 
The  absorbance  of  each  well  was  measured  with  a  plate  reader  (Bio-Rad,  USA; 
Benchmark Plus) at wavelengths of 570 nm (reference) and 450 nm (reading). Plate 
artefacts  that  interfere  with  absorbance  and  contribute  to  background  absorbance 
were  excluded  by  wavelength  subtraction,  where  the  absorbance  at  570  nm  was Chapter 3.                                                                                                                           Materials and Methods                                                                                                                                                                                                                                         
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subtracted from that at 450 nm. Data collection, manipulation (averaging of duplicate 
measurements, blank correction, and wavelength subtraction) and analysis (plotting 
of standard curve and determination of IgA concentration) were performed using 
Microplate Manager (Bio-Rad, USA; version 5.2.1).  
3.7  Statistical Analysis and Graphing Software 
Numerical data for the average of triplicates are reported as the mean ± standard 
error of mean (SEM). Paired t-test was used to test for significant changes after cell 
enrichment. One-way analysis of variance (ANOVA) and the Bonferroni’s post-hoc 
test were used to test for significant differences between culture conditions. P-values 
of <0.05 were considered statistically significant. Statistical analyses and graphing 
were  performed  using  GraphPad  Prism  5  (GraphPad  Software  Inc,  USA;  Mac 
version 4.0b).  
 Chapter 4.                                                                                                  Results I: Experimental Optimisation 
 
  46 
Chapter 4.   Results I: Experimental Optimisation 
4.1  Titrations 
Before  the  staining  reagents  were  used  in  combination  for  enrichment  and 
proliferation  staining,  the  optimal  staining  concentration  for  each  reagent  was 
determined by titration. This was to ensure that each staining reagent provided strong 
positive signals without significant non-specific background staining, which can be 
caused by non-specific binding and cellular autofluorescence.  
Two criteria were used to compare the flow data collected for each titration and 
determine  the  optimal  staining  concentration.  First,  the  optimal  titre  had  to 
demonstrate  minimal  or  no  background  staining,  which  would  be  evident  as 
comparable fluorescence intensity between the negative population for each titre and 
the unstained cell population from the unstained control. Next, the optimal titre had 
to provide clear distinction between the negative and positive populations, at the 
lowest concentration possible.  
Overlaying histograms, which displayed fluorescence intensity on the x-axis and cell 
count  on  the  y-axis,  were  used  effectively  to  compare  the  fluorescence  profiles 
between  dilutions  and  determine  optimal  staining  titres  based  on  the  criteria 
described above. 
The  staining  reagents  that  were  originally  intended  for  the  enrichment  and 
proliferation panel are indicated in Table 4.1. The original enrichment panel was 
designed such that naïve B cells could be positively identified with a marker (IgD) 
that was uniquely expressed by them (Sato et al., 2003; Cariappa et al., 2007), in 
addition  to  the  pan  B  cell  marker  (CD19)  and  memory  B  cell  marker  (CD27). Chapter 4.                                                                                                  Results I: Experimental Optimisation 
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However, V450-IgD titrated poorly, with none meeting the criteria above. Also, as 
the number of alternative fluorochromes available for IgD was limited, the marker 
was excluded from the enrichment panel. 
In addition to the determination of cell proliferation and viability, the markers CD38, 
CD20  and  CD27  were  included  in  the  original  proliferation  panel  to  allow  for 
immunophenotyping of the cells after conditioning. These markers were selected as 
they have been successfully used to identify PBs (CD20
-CD38
+) and memory cells 
(CD20
+CD27
+), albeit with human cells (Dullaers et al., 2009). None of the titres for 
PE-CD20  met  the  criteria  for  optimal  staining  and  hence,  it  was  subsequently 
excluded from the proliferation panel, along with Pacific-CD38 and APC-CD27. PE-
CD19  was  tried,  in  place  of  the  excluded  markers,  as  an  alternative  for 
immunophenotyping  the  conditioned  cells.  However,  immense  spillover  from  the 
signal  of  CFSE  into  the  detection  channel  of  PE-CD19  negated  attempts  at 
compensation. 
Table 4.1 Original set of markers selected for the enrichment and proliferation panel. 
 Panel  Fluorescent Reagent  Clone  Emission Filter 
Enrichment 
V450-IgD MAb  11-26c.2a  450/50 BP 
PE-CD19 MAb  6D5  585/42 BP 
APC-CD27 MAb  LG3.A10  660/20 BP 
LIVE/DEAD Fixable Near-IR Cell Stain  -  780/60 BP 
Proliferation 
Pacific Blue-CD38 MAb  90  450/50 BP 
PE-CD20 MAb  AISB12  585/42 BP 
APC-CD27 MAb  LG3.A10  660/20 BP 
LIVE/DEAD Fixable Near-IR Cell Stain  -  780/60 BP 
CellTrace CFSE Cell Proliferation  -  530/30 BP 
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4.1.1  Monoclonal Antibody Titres 
PE-CD19 MAb was used to identify cells expressing CD19, a  pan-B cell marker, on 
their surface (Kozmik et al., 1992). The optimal staining titre of 0.25 µg/ml (1:800 
dilution) for PE-CD19 was determined from a single overlaying histogram (Figure 
4.1).  
 
Figure 4.1 PE-CD19 MAb titration. Overlay histogram of cells staining positively and negatively 
for  PE-CD19  MAb  at  dilutions  of  1:100,  1:200,  1:400  and  1:800.  Clear  separation  between  the 
positively (higher intensity) and negatively (lower intensity) stained populations was shown for all 
dilutions.  The  unstained  control  (tinted  curve)  overlaps  closely  with  the  negative  peaks  for  each 
dilution, demonstrating low levels of background staining. The chosen titre was 1:800 dilution.   
 
Bio-CD27  used  during  naïve  B  cell  isolation  was  also  used  for  cell  staining  to 
maximise  antibody  usage.  As  biotin  is  non-fluorescent,  APC-SA  was  used  to 
visualise  Bio-CD27  that  was  bound  to  CD27  expressed  on  the  surface  of  cells 
(indirect  staining),  relying  on  the  high  binding  affinity  between  biotin  and 
streptavidin. For convenience, the APC-SA/Bio-CD27 conjugate will be referred to 
as APC-CD27. In all, 16 possible combinations between dilutions of the reagents 
were tested in order to determine to the optimal staining titre for APC-CD27.  Chapter 4.                                                                                                  Results I: Experimental Optimisation 
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The  respective  staining  titres  for  Bio-CD27  and  APC-SA  were  determined  by 
comparing 2 sets of overlying histograms. The first set, comprised of 4 histograms, 
was used to determine the optimal titre for APC-SA. Each histogram corresponded to 
one of the four Bio-CD27 dilutions used and, the 4 dilutions of APC-SA that were 
used with each dilution of Bio-CD27 (Table 3.3) were displayed on the respective 
histogram.  The  best  APC-SA  titre  for  each  histogram  was  determined  after 
comparing APC-SA dilutions of 1:250 and 1:500. The 1:1000 and 1:2000 dilutions 
did  not  produce  positive  signals  (Figure  4.2,  top  panel).  The  optimal  staining 
concentration  for  APC-SA,  when  used  in  conjunction  with  Bio-CD27,  was 
subsequently determined to be 0.8 µg/ml (1:250 dilution).  
The  second  set  was  comprised  of  only  one  histogram,  which  displayed  the  four 
different dilutions of CD27-Bio that was used in conjunction with the optimal titre 
determined  for  APC-SA  (Figure  4.2,  bottom  panel).  The  optimal  staining 
concentration  for  Bio-CD27,  after  comparing  the  four  Bio-CD27  dilutions,  was 
determined to be 2.5 µg/ml (1:200 dilution). 
Close alignment between negative peaks  for the unstained and secondary control 
(APC-SA  only)  showed  no  significant  binding  between  the  secondary  staining 
reagent  and  endogenous  sources  of  biotin  (Figure  4.3).  Consequently,  the  gating 
boundaries for APC-CD27 in subsequent analyses were determined based on CD27 
FMO controls. 
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Figure  4.2  APC-CD27  titration.  Staining with APC-CD27 required a two-step staining protocol 
using biotin conjugated CD27 (Bio-CD27) and allophycocyanin conjugated streptavidin (APC-SA). 
APC-SA  dilutions  produced  different  APC-CD27  staining  intensities  (top  panel),  when  used  in 
conjuction with the same Bio-CD27 dilution (1:200 dilution). Bio-CD27 dilutions produced different 
APC-CD27 staining intensities (bottom panel) for APC-SA. The chosen titre for Bio-CD27 and APC-
SA was 1:200 and 1:250 dilution respectively.  
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Figure 4.3 Secondary control for APC-CD27. Comprised of cells that were labelled directly with 
APC-SA, the secondary control showed no significant contribution to background staining caused by 
the binding of APC-SA to endogenous biotins. 
 
4.1.2  Viability Dye Titre 
LIVE/DEAD Near-IR Fixable Cell Stain, a fluorescent viability dye that reacts with 
amine functional groups present on cellular proteins, was used to identify viable cells 
during  data  collection  and  analysis.  The  dye  readily  permeates  the  disrupted 
membrane of non-viable or injured cells, staining the interior as well as the exterior 
of the cells to yield higher fluorescence intensity. Viable cells with intact membranes 
are less permeable to the dye and stain only on the external surface, resulting in dim 
fluorescence (Perfetto et al., 2006). 
A high proportion of viable cells in the cells suspension resulted in a weak positive 
signal  (Figure  4.4,  top  panel).  Consequently,  non-viable  cells  were  deliberately 
introduced into the single stained control to improve the signal of positively staining 
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provided by the manufacturer, the titres are reported as the volume used. The optimal 
titre for the viability dye was determined to be 0.25 µl. 
 
 
Figure 4.4 Titration of viability dye. Difference in the positive signal before (top panel) and after 
(bottom panel) non-viable cells were added. The chosen titre was 0.5 µL. 
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4.1.3  CFSE Titre 
CFSE was used to track cell division via the mechanism described in Section 1.9.2. 
As expected, all cells stained positively with CFSE. Consequently, the optimal titre 
for CFSE was chosen based on the minimum fluorescence intensity (≥10
3) required 
for distinguishing CFSE peaks and the intensity of the signal (Hawkins et al., 2007). 
A titre of 5 µM CFSE was determined to be optimal for cell labelling, as higher 
concentrations produced fluorescence intensities that were too high (Figure 4.5). The 
same concentration has also been used successfully by others to track B cell division 
in vitro (Dullaers et al., 2009; Seo et al., 2009).  
 
Figure 4.5 CFSE titration. Cells were stained with 5, 10, 15 and 25 µM CFSE. The optimal titre was 
determined to be 5 µM as the peaks for higher concentrations were positioned too far right on the x-
axis.  
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4.2  Compensation Matrix for Enrichment and Proliferation Panels 
Compensation was done to remove by subtraction, the amount of spillover between 
detection channels used in each staining panel, thereby ensuring close representation 
of  the  actual  data  (Roederer,  2001).  The  amount  subtracted  from  each  of  the 
detection channels was determined by FlowJo, after defining positive and negative 
signals for each single stained control. The compensation values were as listed as 
percentages for each matrix (Table 5). Compensation matrices for the enrichment 
and proliferation panels  were determined at  the start  (0 day) of each experiment 
using  single  stained  controls.  These  were  subsequently  applied  to  the  respective 
FMO controls and samples. In the case of the proliferation panel, the same matrix 
was also applied to cells collected at later time points. 
For the two staining panels used in this project, only compensation between APC-
CD27 and the viability  dye was required (Table 4.2), indicating  greater spillover 
between  APC-CD27  and  the  viability  dye,  which  was  expected.  On  the  whole, 
satisfactory compensation was achieved.  
Table 4.2 Representative compensation matrix for the enrichment (left) and proliferation (right) 
panel.  Only  the  fluorochromes  are  indicated  in  each  matrix.  For  convenience,  the  LIVE/DEAD 
Fixable  Near-IR  Dead  Cell  Stain  was  abbreviated  as  LD.  Compensation  was  required  for  the 
enrichment panel but, not the proliferation panels. 
Enrichment panel    Proliferation Panel 
   PE  LD  APC 
 
   CFSE  LD 
PE  -  0%  0% 
 
CFSE  -  0% 
LD  0%  -  2.61% 
 
LD  0%  - 
APC  0%  11.9%  - 
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4.3  ELISA Optimisation 
The  first  assay  performed  according  to  the  manufacturer’s  protocol  yielded  an 
unexpectedly low absorbance range for the mouse IgA standards (Figure 4.6). As 
such, the temperature during sample incubation, detection antibody incubation and 
colour development was raised to 37°C in order to improve antibody binding and 
enzyme activity.  
Optimisation  of  the  manufacturer’s  protocol  increased  the  absorbance  range  for 
serially diluted mouse IgA standards (Figure 4.6), thereby improving the sensitivity 
and  accuracy  of  IgA  quantification.  Compared  to  the  original  protocol,  the 
absorbance  range  had  increased  drastically  when  incubations  were  performed  at 
37°C and colour development was allowed to proceed for 30 min. Extending colour 
development  to  45  min  yielded  the  same  absorbance  range  as  before  (data  not 
shown).  Low  background  staining  was  maintained  in  spite  of  the  modifications, 
indicated by similar absorbance values for the lowest standard (0.39 ng/ml) before 
and after optimisation. Chapter 4.                                                                                                  Results I: Experimental Optimisation 
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Figure  4.6  Standard  curves  for  identical  mouse  IgA  standards  generated  before  and  after 
ELISA optimisation. Duplicate absorbance readings for each standard concentration were plotted as 
mean ± SEM. The range of absorbance was improved when experimental conditions were optimised 
by raising the incubation temperature to 37°C and extending colour development to 30 min. 
 
To be sure that the ELISA kit was specific for mouse IgA, isotype controls of mouse 
IgG1  were  tested  at  concentrations  similar  to  that  of  the  standard.  The  isotype 
controls were also prepared separately in assay buffer and complete media to test if 
the media was interfering with the assay.  
Cross reactivity to the mouse IgG1 isotype control was detected, demonstrating non-
specificity  of  the  kit  for  mouse  IgA.  Higher  absorbances  were  obtained  for 
approximately matching isotype control concentrations that were prepared in assay 
buffer (Figure 4.7), implying binding of mouse IgG1 to the capture and detection 
antibody.  In  stark  contrast,  same  concentrations  of  the  isotype  control  that  were 
prepared  in  complete  media  yielded  absorbances  much  lower  than  the  isotype 
controls that were prepared in assay buffer and IgA standards, indicating possible 
interference from the media.  Chapter 4.                                                                                                  Results I: Experimental Optimisation 
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Figure 4.7 Cross reactivity with IgG1 and media interference. Absorbance of mouse IgA standards 
and  matching  concentrations  of  mouse  IgG1  (isotype  control)  prepared  in  either  assay  buffer  or 
complete media. Duplicate absorbance readings for each standard and isotype control concentration 
and  were  plotted  as  mean  ±  SEM.  When  prepared  in  assay  buffer,  the  isotype  control  yielded 
absorbances much higher than the standards, indicating cross-reactivity. However, isotype controls 
prepared in complete media yielded absorbances much lower than the standards, suggesting inference 
from the culture media. 
 
4.4  LPS Titration  
As conditioning experiments have not been attempted previously, naïve B cells were 
cultured with LPS, alongside the other conditioning mixtures to serve as a positive 
control for cell culture techniques. This was based on the common use of LPS for 
activating naïve B cells in vitro, although it is often used in conjunction with other 
factors such as IL-21 and TGF-β1 (Deenick et al., 1999; Seo et al., 2009).  
Prior  to  experiments  that  involved  the  actual  conditioning  of  naïve  B  cells  with 
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and  10  µg/mL  LPS  to  determine  the  optimal  concentration  for  subsequent 
experiments. Due to experimental limitations, labelled naïve B cells were cultured in 
either concentration for 1, 3 and 6 days only.  
Following  sample  collection,  cells  were  stained  with  the  proliferation  panel  and 
analysed  by  flow  cytometry.  Light  scatter  and  fluorescence  data  collected  were 
displayed on bivariate pseudocolour dot plots, each dot being representative of the 
light  scatter  characteristics  or  fluorescence  intensity  of  a  single  cell,  which  was 
indicated on the axes. The plots display cell frequency as a heat map, with red being 
the region of highest frequency and blue being the least. Early sequential gating was 
performed to remove cells from debris, cell aggregates and non-viable cells from 
consideration during actual analysis.  
Cell viability was determined using cell frequencies that were obtained from the last 
gate drawn during early gating (Figure 4.8). It was expressed as the percentage of 
cells that stained negatively with the viability dye amongst single cells: 
                 
                          
                         
       
 
Cell viability was used to compare between the two LPS concentrations, with an 
increase in viability taken to be indicative of cell proliferation. 1 µg/mL was used in 
subsequent conditioning experiments alongside the conditioning mixtures, since no 
differences in cell viability were observed.  Chapter 4.                                                                                                  Results I: Experimental Optimisation 
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Figure 4.7 LPS titration. Cell viability between 1 µg/mL and 10 µg/mL LPS were similar and hence 
1 µg/mL LPS was used in subsequent experiments. 
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Chapter 5.  Results II: Experimental Findings 
Two processing steps were necessary prior to the conditioning of naïve B cells. First, 
naïve B cells of high purity were isolated by the magnetic depletion of other cell 
types. Next, isolated naïve B cells were labelled with CFSE. These cells were then 
conditioned in four different conditioning mixtures and LPS for either 12 or 7 days. 
Cells and culture supernatants were collected at various time points during the two 
incubation  periods  and  analysed  respectively  for  cell  proliferation  and  IgA 
production.  
5.1  Magnetic Depletion Yielded High Naïve B Cell Purity of ≥93% 
Cell suspensions with high naïve B cell purity were required in order to accurately 
determine the conditioning outcomes, cell division and IgA quantification. Without 
access  to  advanced  flow  cell  sorting  technology  commonly  used  to  obtain  cell 
populations of high purity (≥98%), naïve B cell isolation by magnetic depletion was 
investigated as an alternative method.  
In this project the magnetic depletion was achieved with a commercial kit that was 
modified in order to additionally remove memory (CD19
+CD27
+) B cells. To isolate 
naïve B cells by magnetic depletion of the other cells, splenocyte suspensions were 
incubated  with  antibodies  Bio-TER119,  Bio-CD43  and  Bio-CD4  from  the 
commercial  kit,  and  additionally  Bio-CD27.  Collectively,  these  antibodies  bound 
erythroid cells, plasma cells, B-1 cells, activated B cells and T cells, leaving the 
naïve B cells “untouched” (Wells et al., 1994; Rice and Bucy, 1995; Kina et al., 
2000). Subsequent incubation of the suspension with SA-magnetic beads allowed 
antibody bound cells to be pelleted under the influence of a magnetic field, thereby 
leaving naïve B cells in the supernatant for collection. Samples of the suspensions Chapter 5.                                                                                                         Results II: Experimental Findings 
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obtained before and after enrichment were stained with the enrichment panel and 
analysed by flow cytometry.  
Naïve (CD19
+CD27
-) B cells present in suspensions were identified by the lack of 
memory B cell marker (CD27) expression. As such, the pan B cell marker CD19 
(Kozmik et al., 1992) became an especially important marker for identifying naïve B 
cells. Although CD27 is also expressed on other immune cells and B cell subtypes 
(Tesselaar et al., 2003), these were presumably removed during magnetic depletion.  
On a bivariate pseudocolour dot plot of APC-CD27 (x-axis) versus PE-CD19 (y-
axis), naïve B cells (CD19
+CD27
-) and memory B cells (CD19
+CD27
+) were located 
respectively  in  the  upper  left  and  upper  right  quadrant  (Figure  5.1).  Gating 
boundaries  of  the  quadrant  gates  were  determined  using  CD19  and  CD27  FMO 
controls  (Figure  5.2).  Naïve  B  cell  purity  was  expressed  as  the  percentage  of 
CD19
+CD27
- cells amongst viable cells:  
                    ( )   
                                    
                               
       
 
Figure  5.1  Naïve  B  cell  purity  before  and  after  isolation.  Bivariate  dot  plots  for  a  single 
representative experiment of cells stained with PE-CD19 and APC-CD27 before and after isolation. 
Naive B cells and double positive memory B cells were located respectively in the upper left and 
upper right quadrants. Double negative cells were located in the lower left quadrant while CD19-
CD27+ cells were in the lower right quadrant. Chapter 5.                                                                                                         Results II: Experimental Findings 
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Figure 5.2 Gating based on CD19 and CD27 FMO control. A quadrant gate was used to identify 
naïve B cells (upper left quadrant) on a APC-CD27 versus PE-CD19 dot plot. Cells that stained 
negatively for CD19 in the CD19 FMO control and CD27 in the CD27 FMO control were used to 
determine the boundaries of the quadrant gate. 
 
The modified enrichment protocol yielded a significant increase (1.72 ± 0.05 fold, 
n=3) in the proportion of naïve B cells after enrichment (P<0.001, n=3), averaging 
93.2 ± 0.7 %. The proportion of double negative cells (CD19
-CD27
-) represented in 
the lower left quadrant was significantly reduced after enrichment (P<0.001, n=3). 


































Figure 5.3 The average naïve B cell purity before and after enrichment. The proportion of naïve 
B (CD19+CD27-) cells after enrichment had increased significantly. Mean ± SEM, n=3. *** indicates 
P<0.001 Chapter 5.                                                                                                         Results II: Experimental Findings 
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5.2  Modified Separation Protocol Removed CD27
+ Subpopulations to 
Different Extents  
Bio-CD27 MAb was designed into the separation protocol to specifically remove 
memory (CD19
+CD27
+) B cells. This was performed as an added precaution, due to 
uncertainty about the efficacy of memory B cell removal with anti-CD43 (Wells et 
al., 1994). Memory B cells were not of interest as they have previously undergone 
activation,  cell  division  and  class-switching  in  vivo,  which  would  confound  the 
results  obtained  for  conditioned  naïve  B  cells,  should  they  respond  to  the 
conditioning mixture. The volume of Bio-CD27 added was derived from the titration 
results for Bio-CD27 and APC-SA. When titrated at 1:100 dilution (0.50 µg/ml), 
Bio-CD27  displayed  a  slight  increase  in  background  staining  (result  not  shown), 
which was deemed to be caused by antibody saturation. As such, 100 µl Bio-CD27 
was  determined  to  be  sufficient  for  complete  removal  of  CD27
+  cells  (including 
memory B cells) contained within the splenocyte suspensions of 2 x 10
7cells/ml. The 
total volume of streptavidin particles used was scaled up accordingly to a 1:1 ratio to 
accommodate  the  addition  of  Bio-CD27.  The  ratio  was  inferred  from 
recommendations by the manufacturer that equal volumes of the antibody cocktail 
and streptavidin particles be used.  
Overall, a significant proportion of CD27
+ cells were removed during the enrichment 
process (P<0.001, n=3), accounting for 1.7 ± 0.3% of the enriched cell population 
(Figure 5.4). The significance seemed to be attributed to the removal of CD19
-CD27
+ 
cells rather than memory B cells (CD19
+CD27
+), which remained relatively constant. 
The  low  proportion  of  memory  B  cells  suggests  that  these  cells  are  unlikely  to 
contribute to the outcomes determined for conditioning experiments. Chapter 5.                                                                                                         Results II: Experimental Findings 
 
















































































Figure 5.4 Removal of CD27+ cells after enrichment. Comparison of the proportion of all CD27+ 
cells (top panel) and CD19+CD27+ memory B cells (lower panel) before and after enrichment. Most 
of the CD27+ cells removed during enrichment were CD19-CD27+ cells. Data are presented as mean 
± SEM. *** indicates P<0.001. Chapter 5.                                                                                                         Results II: Experimental Findings 
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5.3  Trends in Cell Viability Revealed Extent of Cell Proliferation 
CFSE  labelled  naïve  B  cells  were  cultured  in  a  total  of  6  different  conditions, 
including LPS and complete media. Each of the 4 different conditioning mixtures 
was assigned a condition number. Condition 1 contained a mixture of anti-IgM, anti-
CD40, IL-2 and CpG, which was also present in conditions 2 to 4. These reagents 
were used to mimic most aspects of naïve B cell activation in vivo, such as BCR 
engagement, TH cell co-stimulation, cytokine signalling and TLR engagement. IL-21 
was added to condition 2, while TGF-β1 was added to condition 3. Both cytokines 
are well known IgA class-switching factors (Dullaers et al., 2009; Seo et al., 2009). 
Condition 4 contained both IL-21 and TGF-β1 in addition to the mixture used in 
condition 1. In all, three naive B cell conditioning experiments, excluding the trial 
experiment with LPS, were conducted. 
Cell viability was used as an indicator of cell proliferation (Figure 4.8), thus allowing 
comparisons to be drawn between culture conditions. The viability of cells cultured 
under different conditions was determined at each time point. Cell samples collected 
at  each  time  point  were  assessed  for  cell  viability  to  determine  changes  in 
proliferative responses over time. The viability of freshly labelled cells that were put 
into culture at 0 day was consistent, averaging 83.9 ± 0.7% (n=3).  
The initial time course of 12 days was chosen to replicate the culture duration over 
which naïve human B cells (Dullaers et al., 2009) were conditioned with the same 
reagents  used  in  this  project.  As  expected,  cell  viability  decreased  over  time  for 
unstimulated cells (negative control), showing that the complete media alone had no 
stimulatory properties (Figure 5.5). An exception was observed when cell viability 
increased sharply from 1.1% at day 9 to 26.9% at day 12. Although the anomaly Chapter 5.                                                                                                         Results II: Experimental Findings 
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observed at 12 days could not be accounted for, culture contamination was ruled out 
as a possible factor since the culture supernatant did not appear cloudy, which is a 
cardinal  sign  of  contamination.    Observation  of  the  collected  culture  supernatant 
under an inverted microscope did not reveal the presence of any bacteria or fungi.  
The observed decline in cell viability after 3 days in culture resulted in revision of 
the  culture  duration  to  7  days  for  the  next  two  experiments,  with  samplings 
performed on alternate days to allow the tracking of cell viability with greater fidelity. 
Despite similarities in the overall trend, cell viability declined even more rapidly 
after 3 days in these cultures (Figure 5.6), indicating either an increased rate in cell 
death  or  reduced  rate  of  proliferation.  An  immediate  explanation  could  not  be 
provided. In hindsight, the difference could have been caused by use of different lots 
of conditioning reagent, although this warrants further investigation.  



























Figure  5.5  Viability  of  cells  cultured  in  different  conditions  for  12  days.  Cell  viability  for 
conditions 1 to 4 and cells cultured in LPS recovered at day 3 and 6 respectively. Cell viability 
eventually dropped below 20%, with day 12 from the longer time course being an exception. n=1. 
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Figure 5.6 Viability of cells cultured in different conditions for 7 days. Cell viability for conditions 
1 to 4 and cells cultured in LPS recovering at day 3 and 6 respectively. Cell viability eventually 
dropped below 20% by day 7. n=2. 
 
The viability of cells cultured in conditions 1 to 4 showed signs of recovery at day 3 
for  all three experiments,  indicating  cell proliferation. Nevertheless,  cell  viability 
dropped over time to ≤20% at the end of each time course. Additional evidence for 
cell  proliferation  was  also  supported  by  microscopic  observations,  with  visually 
detectable differences in the size of the cell masses between the conditioned cells and 
cells cultured in LPS or complete media (data not shown). In addition to increasing 
cell viability, yellowing of the culture media was observed at day 3 for cells cultured 
with the conditioning mixtures. The colour change is often associated with increased 
media acidity, caused by the accumulation of acidic by products of metabolically 
active cells. As such, it appears that the proliferating cells were exhausting the media 
after 3 days in culture.  
Cell viability for cells conditioned with LPS plummeted in the first 3 days, before 
showing signs of recovery at 6 day, albeit at much lower values compared to the 
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cultured with LPS or in complete media, suggesting that fewer cells were dividing at 
a  slower  rate.  It  could  also  suggest  that  the  cells  were  dying  much  sooner  than 
expected.  
5.4  Comparing  Cell  Divisional  Responses  Between  Different 
Conditions 
Although  the  cell  viability  trend  described  before  provided  some  insight  on  the 
extent of cell proliferation, the number of divisions could not be inferred and had to 
be  determined  separately.  This  would  allow  division  number  to  be  examined  in 
relation to the amount of IgA present in culture supernatants, since class-switching is 
strongly associated with cell division (Hodgkin et al., 1996).  
The number of divisions undergone by viable cells cultured in each condition was 
estimated by CFSE labelling of naïve B cells prior to conditioning. Cells collected 
after conditioning were stained with the proliferation panel and analysed by flow 
cytometry. 
CFSE histograms, with CFSE intensity was plotted on the x-axis and cell count was 
plotted on the y-axis, of viable cells were used to determine cell division numbers 
with the Proliferation tool on FlowJo. The tool determined cell division numbers by 
fitting of peaks onto the histograms. The height of the peak or rather, the area under 
the peak, was indicative of the number of cells.  
The position of the undivided peak was determined by fitting a single peak, since 
there was no cell division, onto the CFSE histogram of the undivided control. This 
peak  was  imposed  onto  the  histograms  of  samples  collected  on  the  same  day. 
Starting at undivided peak for each sample histogram, peaks of sequentially halving 
fluorescence intensity were fitted onto the histogram (Figure 5.7). The position of the Chapter 5.                                                                                                         Results II: Experimental Findings 
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peak in relation to that of the undivided control was indicative of the number of 
divisions. (Lyons and Parish, 1994).  
  
Figure 5.7 Estimation of cell division by analysis of CFSE fluorescence intensity. CFSE profiles 
of viable cells cultured under different conditions. were displayed on a histogram. Using the CFSE 
profile of the undivided control (left) as a reference for the position of the undivided peak, Gaussian 
peaks of sequentially halving CFSE intensity were fitted onto the profile of cells cultured under a 
particular condition (right). The number of divisions was equivalent to the number of peaks fitted.  
 
For  comparison  of  the  proliferative  responses  between  culture  conditions,  two 
parameters derived from the number of cell divisions were used. The first parameter 
was the percentage of divided cells, which provided an estimation of the proportion 
of cells that were activated by the conditioning reagents and have undergone division. 
The  other  parameter  used  was  the  proliferation  index,  which  averaged  the  total 
number of divisions over the number cells that have undergone at least one division. 
As such a high proliferation index suggests that the activated cells have undergone 
numerous divisions.  
The  3  day  time  point  was  common  to  all  conditioning  experiments,  providing  a 
minimum sample size (n=3) on which statistical differences could be determined. As 
it  coincided  with  maximum  cell  viability  for  cells  cultured  in  conditions  1  to  4 Chapter 5.                                                                                                         Results II: Experimental Findings 
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(Figure  5.6),  the  percentage  of  divided  cells  and  proliferation  index  was  derived 
respectively for each condition, LPS and complete media. As cell proliferation was 
not detected in the negative control (Section 5.3), proliferation index and percentage 
of cells divided cells was assumed to be zero. ANOVA was performed on these 
parameters to determine if the culture conditions were statistically different from 
each  other  and,  if  indeed,  the  Bonferroni‘s  post-hoc  test  was  used  to  determine 
differences  between  specific  conditions.  As  the  sample  sizes  were  too  small  for 
normality  testing,  cell  division  number  and  the  parameters  derived  from  it  were 
assumed to be normally distributed. 
ANOVA revealed significant differences amongst the conditions for percentage of 
cells  divided  cells  (F(5,12)  =  28.74,  P<0.001)  and  proliferation  (F(5,12)  =  84.54, 
P<0.001). Further testing with the Bonferroni’s post-hoc test revealed that most of 
the significant differences were determined against the negative control, which was 
expected (Figure 5.8).  
Significant differences were observed between LPS and each of the conditioning 
mixtures for the percentage of cells divided cells (P<0.001), but not proliferation 
index. These results implied that LPS was causing a small proportion of naïve B cells 
to divide persistently, while the conditioning mixtures caused a large proportion of 
cells to undergo lesser rounds of division. 
Both the percentage of cells divided cells and proliferation index did not reveal any 
significant differences between any of the conditioning mixtures, indicating that IL-
21 and TGF-β1 might not have any effect on naïve B cells. As such, the proliferative 
responses observed (Section 5.3) were probably induced by the combinatorial effect 
of anti-IgM, anti-CD40, IL-2 and CpG.  Chapter 5.                                                                                                         Results II: Experimental Findings 
 
























































Figure 5.8 Comparison of % cell divided and proliferation index for different culture conditions 
at day 3. No significant differences were detected between conditions 1 to 4 for percentage of cells 
divided  cells  (F(5,12)  =  28.74,  P<0.001)  in  the  top  panel  and  proliferation  index  (F(5,12)  =  84.54, 
P<0.001) in the bottom panel, indicating similar cell responses (n=3). Significant differences were 
detected between LPS and each of the conditioning mixtures for  percentage of cells divided cells 
(P<0.001) but not for proliferation index. Data are presented as mean ± SEM. *** indicates P<0.001. Chapter 5.                                                                                                         Results II: Experimental Findings 
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5.5  Majority of Conditioned Cells Underwent 3 Rounds of Division 
Indications  that  the  conditioning  mixtures  were  not  causing  cells  to  divide 
persistently  prompted  further  investigation  on  cell  division,  since  IgA  class-
switching and its subsequent production is dependent on cell division (Hodgkin et al., 
1996). As such, cell division numbers for condition 4, the mixture of most interest, 
were examined in relation to culture duration. This was done by comparing CFSE 
histograms of the different time points, after peaks were fitted onto each histogram 
for estimating cell division number (Figure 5.7).  
A leftward shift (decreasing CFSE intensity) in the position of the undivided peak 
was observed over time. This was caused by the slow background decay of CFSE 
that does not interfere with the determination of cell division number (Hawkins et al., 
2007). The apparent increase in CFSE intensity on day 5 and 7 of the shorter time 
course was most likely caused by the use of different cytometers, albeit of the same 
model and identical acquisition parameters. This was due to a temporary malfunction 
of the cytometer located at Murdoch University and hence, some samples had to be 
analysed at CMCA, UWA.  
Shown in Figure 5.9, cell division was not observed at day 1, for both the twelve and 
seven day time courses, indicated by similar CFSE intensities between the undivided 
control  and  samples  collected  at  day  1  (data  not  shown).  The  total  number  of 
divisions increased over time, reaching 7 divisions by day 9 during twelve day time 
course and 5 divisions by day 5 during the seven day time course. A drop in number 
of divisions at day 7 was observed for the latter, possibly due to rapidly declining 
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undergone that many rounds of division. Cell division could not be estimated on day 
12 as the number of viable cells was insufficient for analysis.  
Despite the  increase in  number of cells  dividing with  time, the majority  of cells 
appeared only to have undergone 2 to 3 rounds of division. This was evident with the 
taller peaks being centred between much shorter peaks (Figure 5.9). Culture media 
exhaustion,  as  described  earlier,  could  have  caused  the  apparent  arrest  of  cell 
division beyond 3 rounds. 
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Figure 5.9 Changes in the number of cell divisions for cells cultured over 12 days and 7 days in 
condition 4. Starting with 0 division at day 1, cells cultured over 12 days (left column) reached 6 
divisions by day 9 while those cultured over the shorter time course reached 5 divisions by day 5. A 
drop in the number of divisions was observed at day 7 for the shorter time course (right column) 
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Chapter 6.  Discussion 
The conditions used in this project for naïve B cell conditioning were essentially 
replicating two important events that are important for plasma cell development in 
vivo. The first is naïve B cell activation that occurs within the lymphoid follicles of 
peripheral lymphoid tissues, where naïve B cells become activated following cognate 
antigen encounter and, usually, co-stimulation by TH cells. The second event occurs 
within germinal centres of lymphoid follicles, where activated B cells within the dark 
zone of germinal centres undergo CSR. The purpose of CSR is to rearrange the genes 
coding for the heavy chain components of BCRs expressed on centroblasts, thereby 
allowing  BCRs  of  different  isotypes  to  be  released  as  antibodies  after  they 
differentiate into plasma cells. The gene rearrangement process involves the deletion 
of  genes  and  as  such,  requires  cell  division  for  successful  switching  to  different 
isotypes.  
6.1  Magnetic Isolation for Obtaining High Naïve B Cell Purity 
Cell suspensions with high naïve B cell purity were required for the conditioning 
experiments  conducted  in  this  project,  so  as  to  obtain  responses  that  were 
representative of naïve B cells. This posed the first major challenge of this project, 
since access to flow sorting was not readily available. Although flow sorting services 
at another institution (CMCA) could be engaged, there were major concerns over the 
loss of viable cells during transport (Chokeshai-u-saha et al., 2012), which would 
impact  the  number  of  cells  available  for  conditioning.  Consequently,  magnetic 
depletion  was  investigated  as  a  simpler  alternative  to  flow  sorting  for  the 
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A  high  purity  of  naïve  B  cells  (≥93%)  was  isolated  by  magnetic  depletion, 
specifically negative selection (Section 8.1). There were significant increases in the 
purity of naïve B cells (P<0.001) obtained before and after isolation. While this was 
just short of the aim (≥95%), the average purity obtained was comparable to those 
reported by others (90-92%) that have used the same isolation method, albeit from 
different suppliers (Jiang et al., 2007; Chokeshai-u-saha et al., 2012). As such, it was 
concluded that the kit was working reasonably well, even after modifications were 
made to include the removal of CD27
+ cells, including memory B cells.  
Memory B cells were not desired as they would respond differently from naïve B 
cells  when  conditioned  (Shi  et  al.,  2003)  and  thus,  interfere  with  the  responses 
measured. Unexpectedly, comparisons of the changes in memory B cell numbers 





- cells were removed following magnetic depletion. 
The  implications  of  these  findings  remain  unclear  but,  may  be  related  to  the 
separation process  or antibody markers used. Furthermore, the few markers used 
provided  limited  insight  into  the  cell  types  present.  Nevertheless,  in  light  of  the 
overwhelming number of naïve B cells obtained post separation, the outcomes of the 
conditioning experiments were not expected to be greatly affected by relatively small 
numbers of memory B cells and the other two cell populations.  
Although  flow  sorting  produces  higher  cell  purity  than  magnetic  separation 
(Chokeshai-u-saha  et  al.,  2012),  negative  selection,  which  leaves  naïve  B  cells 
“untouched” lends an advantage to the latter method. This is due to the alteration of 
BCR signalling with MAbs (CD19 and IgD) associated with the positive labelling of 
naïve B cells (Pezzutto et al., 1987; Healy et al., 1997; Chen et al., 2013). This 
highlights the possibility of altering conditioning outcomes as a result of flow sorting. Chapter 6.                                                                                                                                                   Discussion 
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In summary, the isolation of naïve B cells by magnetic bead-based negative selection 
is a safer option than flow sorting, have a lower risk of incurring mixed naïve B cell 
responses. 
6.2   Naïve B Cell Activation 
Anti-IgM, anti-CD40, IL-2 and CpG were used in this study for the activation of 
murine naïve B cells  to  replicate TI  and TD activation of naïve B cells in  vivo. 
Cognate antigen recognition by naïve B cells, which is the first step in activation and 
often results in the partial activation of naïve B cells, was replicated by the use of 
plate bound anti-IgM. As most BCRs expressed on the surfaces of naïve B cells are 
of the IgM isotype (Fleire et al., 2006), anti-IgM binds non-discriminately to these 
BCRs and provides initial stimulation to a large number of naïve B cells of differing 
antigen  specificity.  While  this  situation  is  unlikely  to  occur  in  vivo,  polyclonal 
activation could be ideal for conditioning as it activates naïve B cells with different 
antigen  specificities.  This  would  allow  magnetic  separation  to  be  used  for  the 
selection of antigen-specific B cells (Egeland et al., 1988). Furthermore, selection 
would  be  easier  with  the  increase  in  number  of  antigen  specific  cells  following 
polyclonal activation. 
6.2.1  TD Activation  
Anti-CD40 and IL-2 were used to replicate TD activation of naïve B cells in vitro, 
which would be provided in vivo by TH cells to partially activate naïve B cells. Anti-
CD40  binds  to  CD40  expressed  on  naïve  B  cells,  mimicking  engagement  with 
CD40L that is expressed on TH cells. This triggers expression of the transcription 
factor NFκB, which in turn directs the expression of proteins that are crucial for cell 
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expressed on the surfaces of naïve B cells, acting as a growth factor and mimicking 
co-stimulation provided by cytokines in vivo (Waldmann et al., 1984).  
6.2.2  TI Activation  
T cell independent activation of murine naïve B cells in vivo was replicated by the 
use of CpG that engages TLR9 (Gururajan et al., 2007). These nucleotides, which are 
closely associated with pathogen DNA, binds to TLR9 expressed on naïve B cells 
and trigger the expression of NFκB as described for anti-CD40. As TLR9 is also 
expressed on memory B cells, these cells that are present in culture could also have 
responded to CpG in the culture media. However, their contribution to overall cell 
proliferation would be negligible, since they were only present in small numbers 
(~1%).  
Cells cultured with LPS were activated differently, via TLR4. The expression level 
of TLR4 on naïve B cells is approximately five times lesser than TLR9 and thus, the 
stimulatory capacity of CpG would be greater than LPS (Gururajan et al., 2007). 
Although the activation pathway is different from  those used in the conditioning 
mixtures, LPS was chosen as it is commonly used for the activation of naïve B cells 
in vitro (Deenick et al., 1999; Seo et al., 2009).  
6.3   Cell Proliferation  
In fulfilment of the second aim, cell proliferation was successfully demonstrated with 
the conditioning mixtures used in this experiment. Cell viability had increased at day 
3, indicating that the proportion of viable cells was increasing and, thus proliferating. 
Proliferation  of  the  conditioned  cells  was  also  supported  by  the  high  percentage 
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have undergone between 5 to 7 divisions. In view of the relationship between cell 
division and class-switching, IgA production was expected in these cultures.  
Although naïve cells cultured in each of the conditioning mixtures were proliferating, 
no significant differences were observed between the mixtures. As anti-IgM, anti-
CD40, IL-2 and CpG were common to each mixture, a superficial interpretation of 
the results would be that IL-21 and TGF-β1, when used separately or together, were 
not having any effect on cell proliferation. A comprehensive interpretation of the 
results would, however, require an account of the effects each individual component 
has on cell proliferation and all possible interactions between them. Given that these 
additional conditions were not tested, an in depth discussion on the implications of 
this finding was not possible. As such, the following discussion presents published 
evidence for the effect of IL-21 and TGF-β1, and highlights some of the challenges 
faced with the interpretation of such data. 
In vivo, activated B cells within GCs would receive IL-21 and TGF-β1 from TFH 
when they migrate into the light zone following clonal expansion. These cytokines 
bind to the respective receptors, IL-21 receptor (IL-21R) and TGF-β receptor (TβR), 
which  are  expressed  on  the  surface  of  B  cells.  The  binding  of  these  cytokines 
mediates growth and differentiation of activated B cells into plasma cells (Kehrl et 
al., 1986; Parrish-Novak et al., 2000). The effect IL-21 has on proliferation can be 
either positive or negative, as demonstrated respectively when used in combination 
with anti-CD40 or, anti-IgM and IL-4 (Parrish-Novak et al., 2000). However, these 
observations could not be used to relate to the effect of IL-21 in this experiment 
when  both  anti-CD40  and  anti-IgM  were  used,  therefore  demonstrating  the 
complexity  that  is  associated  with  attributing  differences  to  specific  components 
within a set of conditioning reagents used. Chapter 6.                                                                                                                                                   Discussion 
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In addition to proliferation, the importance of IL-21 in B cell differentiation was 
highlighted  by  a  study,  carried  out  in  mice  deficient  for  IL-21R,  which  showed 
severe defects in antibody production (Ozaki et al., 2002). Furthermore, abrogation 
of IL-21 activation resulted in the inhibition of B cell activation, proliferation, and 
antibody  production  (Bryant  et  al.,  2007;  Kuchen  et  al.,  2007).  As  such,  it  was 
unexpected that none of these reported effects of IL-21 were observed in this study. 
Perhaps, the experiments performed would require optimisation, by performing dose 
titrations of IL-21 in conjunction with the established concentrations of anti-IgM, 
anti-CD40, IL-2 and CpG, to better appreciate the role of IL-21 in this study.  
Similar  to  IL-21,  TGF-β1  can  exert  stimulatory  and  inhibitory  effects  on  B  cell 
growth and differentiation. When TGF- β1 was added at low concentrations to cells 
that were activated with IL-2, B cell proliferation and antibody production were both 
suppressed (Kehrl et al., 1986). However, the suppression of proliferation, but not 
antibody  production,  was  partially  lifted  with  increased  concentrations  of  IL-2. 
Again, the study conducted by Kerhl, Roberts et al. (1986), which only examined the 
effect for two of the six conditioning reagents used in this study, has highlighted the 
potential  complications  that  maybe  involved  in  interpreting  the  overall  cell 
proliferation with respect to each component used. As suggested for IL-21, it seems 
that the concentration of TGF-β1 used may need to be optimised in relation to fixed 
concentrations of anti-IgM, anti-CD40, IL-2 and CpG. 
One interesting observation was made when the proliferation index and percentage of 
divided cells of conditioning mixtures were compared against the LPS condition, 
which  was  meant  to  serve  as  a  comparison  for  proliferative  responses.  While 
significant differences in the percentage of divided cells (P<0.001) were observed 
between LPS and the conditioning mixtures, none were observed for the proliferation Chapter 6.                                                                                                                                                   Discussion 
 
  81 
index. As proliferation index averages the total number of divisions for all dividing 
cells, the results suggests that although a smaller number of cells were proliferating 
later with LPS than with the conditioning mixtures, these cells were also undergoing 
more divisions.  
Although  LPS  activates  naïve  B  cells  via  TLR4,  it  was  chosen  as  a  control  for 
comparing proliferative responses as it a known B cell mitogen (Andersson et al., 
1973; Coutinho et al., 1973). B cell mitogens are polyclonal activators of B cell 
proliferation and hence, the proliferative responses of cells cultured with LPS would 
serve as a benchmark for those observed with cells cultured in conditioning mixtures. 
In this regard, the proliferation of cells, as measured by the number of divisions 
undergone  by  cells  (proliferation  index)  cultured  in  conditioning  mixtures,  was 
markedly increased above those cultured in LPS.  
In  view  of  the  significant  differences  seen  with  percentage  of  divided  cells,  the 
results indicate that a mixture of anti-IgM, anti-CD40, IL-2 and CpG at least, is 
capable of activating a lot more (~70%) cells than LPS. Based on the proliferation 
index,  it  seems  likely  that  the  concentrations  of  IL-21  and  TGF-β1  used  were 
insufficient to exert any of their discussed effects on the large proportion of dividing 
cells, contradicting the complete absence of influence from IL-21 and TGF-β1 that 
was proposed earlier based on the cell viability. This seems to provide a reasonable 
account  for why the majority of cells  have only  undergone 3 rounds  of division 
(Figure 5.9). By inference then, cells cultured with LPS would have to undergo more 
than 2 to 3 rounds of division in order to account for the differences between the 
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Nevertheless, this interpretation maybe oversimplified as other differences have not 
been considered. For instance, the different trend in cell viability observed between 
the two time courses, the differences in time taken for cell viability to recover and, 
the  possible  mechanistic  differences  that  may  be  attributed  to  TLR9  and  TLR4 
activation of naïve B cells (Richard et al., 2008). Due to the complexity of such 
systems, which is discussed in detail by Hodgkin, Chin et al. (1997), satisfactory 
explanations for these differences could not be provided. However, in hindsight, dose 
titrations  for  IL-21  and  TGF-β1,  as  suggested  before,  might  provide  additional 
insight into their respective roles in this conditioning system.  
In summary, each of the conditioning mixtures has driven strong cell proliferative 
responses, enabling some cells to undergo 5 to 7 divisions. These numbers provide 
early  evidence  for  IgA  production,  based  on  the  relationship  between  division 
number and class-switching.  
6.4   IgA Production 
IgA production could  not  be ascertained  from  this  study,  as  the ELISA kit  used 
demonstrated  cross-reactivity.  Furthermore,  cell  culture  media  interference  was 
demonstrated,  which  would  interfere  with  absorbance  readouts.  As  such,  this 
discussion will focus on the expected outcome based on previous published findings. 
IgA production has been observed after cells activated in culture have undergone 5 
divisions (Deenick et al., 1999; Dullaers et al., 2009). Based on the 5 to 7 divisions 
that were determined for the conditioned cells in this study, the presence of IgA in 
culture supernatants would be expected. This prediction is based on the established 
relationship between class-switching and cell division (Hodgkin et al., 1996), as AID 
required for initiating class-switching is regulated by cell division (Rush et al., 2005). Chapter 6.                                                                                                                                                   Discussion 
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Nevertheless, it is important to be aware that IgA may not be the only antibody class 
that could have been produced. It seems IgG2b could also be produced, as reports 
have shown that TGF-β1 induces  the production of  IgA  and  IgG2b by initiating 
transcription at the switch regions of heavy chains genes that code respectively for 
IgA and IgG2b (Lebman et al., 1990; Seo et al., 2009). Although the addition of IL-
21  supposedly  decreases  TGF-β1-induced  IgG2b  but  not  TGF-β1-induced  IgA 
expression (Seo et al., 2009), it would still be ideal to establish the amount of each 
isotype produced by cells conditioned in this study.  
Several  different  methods,  in  addition  to  ELISA,  can  be  used  to  establish  IgA 
production, although ELISA is still the preferred method due to its ease and cost of 
operation. One alternative would be to employ capture bead array, which involves 
the capture of IgA with beads that are subsequently analysed by flow cytometry 
(Elshal  and  McCoy,  2006).  Other  useful  methods  include  the  detection  of  IgA 
surface  expression  by  flow  cytometry  or  immunohistochemistry  (Dullaers  et  al., 
2009),  and  polymerase  chain  reaction  (PCR)  detection  of  germline  transcripts 
corresponding to IgA (Seo et al., 2009), which may also provide information about 
the regulatory events surrounding IgA production. Given that culture supernatants 
remain to be analysed and, the accessibility to flow cytometry, cytometric bead array 
would probably be the best method. 
6.5  Immunophenotyping for Better Resolution of B Cell Populations 
The successful inclusion of IgD into the enrichment panel, which was unable to be 
optimised in the timeframe of this project, would have aided the interpretation of 
results. When used in conjunction with CD19 and CD27, IgD expressed uniquely on 
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to  the identity of naïve B cells,  as  opposed to the weak inferences  made in  this 
project by excluding CD27 expressing cells. In addition, recent evidence indicates 
that the use of CD19, CD27 and IgD is not only limited to the identification of naïve 
B cells.  
Five different human B cell subpopulations have been identified using CD19, CD27 
and IgD MAbs (Rodríguez-Bayona et al., 2010). The two populations  of B cells 




-) and plasma cells (CD19
+CD27
++IgD
-). CD19, CD27 and IgD, 
which  are  also  expressed  on  mouse  B  cells,  could  have  be  used  to  distinguish 
between naïve B cells and double negative memory B cells in the enriched fractions 
(Klein  et  al.,  2003).  This,  however,  has  raised  doubts  about  the  identity  of 
(CD19
+CD27
-) naïve B cells isolated in this project and the subsequent conditioning 
outcomes  that were determined, which  could  be confounded by the responses of 
negative  memory  B  cells.  Unfortunately,  this  question  could  not  be  adequately 
addressed within the span of this  project.  Nevertheless, future experiments  using 
CD19, CD27 and IgD MAbs would potentially be able to clarify this issue and allow 
for  better  interpretation  of  the  results  by  taking  the  responses  of  different 
subpopulations into consideration.  
Another application for CD19, CD27 and IgD would be their incorporation into the 
proliferation panel. This would circumvent the use of PE-CD20 MAb and allow for 
better  delineation  of  the  B  cell  subpopulations  as  compared  to  the  original 
proliferation panel of CD20, CD38 and CD27. Regardless of panel design, the main 
intention behind immunophenotyping of the conditioned cells was to determine the 
relative proportion of memory B cells and plasma cells. The results obtained from Chapter 6.                                                                                                                                                   Discussion 
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this new panel can improve the results of this study in two ways, each of which 
would benefit this study greatly.  
The first improvement would be of greater relevance to the long term goals of this 
project. As the ultimate goal of this project was to direct homing IgA PBs to the 
respiratory mucosa where they can boost antigen specific IgA humoral responses, the 
conditioning mixture that generates a much higher proportion of PBs than memory 
cells, as determined by immunophenotyping, would demonstrate greater therapeutic 
potential and should be investigated in future studies.  
Additionally, differences in the proportions of memory B cells and plasma cells that 
were  generated  by  the  conditioning  mixtures  can  be  better  analysed  as  effects 
mediated by either IL-21, TGF-β1 or both cytokines, thereby providing some insight, 
at the cellular level, into how these two factors might determine the fate of cells 
emerging from GCs in vivo. As much of the molecular mechanisms involved remain 
largely unknown (Zotos and Tarlinton, 2012), an additional outcome, that could be 
achieved  in  parallel  with  a  broader  attempt  to  condition  B  cells,  would  be  the 
expansion of existing knowledge of these mechanisms, possibly by genetic studies. 
The information obtained, as such, would complement conditioning studies, thereby 
creating a comprehensive approach for investigating the potential of conditioning 
naïve B cells in vitro for therapeutic applications. 
6.6  Refining CFSE Labelling for Better Determination of Cell Division 
The main problem encountered when determining cell division was poor resolution 
of the CFSE histograms (Section 8.5). Unlike those shown in Figure 5.9, the peaks of 
CFSE histograms published in the literature could be distinguished visually (Lyons 
and Parish, 1994; Hodgkin et al., 1996), allowing easy determination of cell division Chapter 6.                                                                                                                                                   Discussion 
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number. Without such distinguishable peaks, cell division number was determined in 
this project by fitting peaks at sequentially halving intensities from the undivided 
peak, based on the assumption that cell division leads to an equal sharing of CFSE 
between  daughter  cells.  This  has  been  shown  to  be  valid  for  several  rounds  of 
division, however these results raise questions about the basis of poor resolution in 
this study (Lyons and Parish, 1994).  
Further investigations into the possible causes for poor resolution revealed uneven 
staining as the most probable cause. Referring to the protocol that was published by 
researchers  from  the  laboratory  that  first  detailed  the  use  of  CFSE  labelling  for 
tracking lymphocyte division, even cell numbers as high as 1 x 10
8 were stained in a 
total volume of 1 mL. Furthermore, homogeneous staining within this small staining 
volume was achieved quickly within 5 min (Quah et al., 2007). Compared to the 
protocol used here where the labelling of 3 x 10
7 cells that was done in a much larger 
volume of 30 mL for 10 min in this study, homogenous staining would have been 
difficult to achieve. In future, CFSE labelling with the same number of cells should 
be done in a volume of 1 mL, with immediate vortexing after the addition of CFSE to 
promote rapid and homogenous staining (Quah et al., 2007).  
6.7  Future Directions 
Undoubtedly, this study has raised several interesting questions. For one, the impact 
of  IL-21  and  TGF-β1  on  cell  proliferation  in  relation  to  the  other  conditioning 
reagents  and,  how  it  subsequently  relates  to  IgA  production  requires  immediate 
attention. As such, simple dose titrations for each conditioning reagents may shed 
light on future approaches. The next question is IgA production. Until this key piece 
of information is obtained, the ultimate success of the study remains uncertain. In Chapter 6.                                                                                                                                                   Discussion 
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view of the resources available, alternative commercial ELISA kits could be tested or, 
flow cytometry can be used to check for surface expression of IgA on conditioned 
cells. The next step after affirming IgA production would be to determine the surface 
expression of homing receptors, including CCR10, which directs the homing of IgA 
PBs  to  mucosal  sites.  Success  with  the  characterisation  of  homing  receptor 
expression would then lead to studies on the migration capabilities of PBs generated 
by naïve B cell conditioning, both in vivo and in vitro. 
6.8  Conclusion 
In this study, a modified protocol for the magnetic isolation of naïve B cells has been 
established, producing naïve B cell populations of high purity that can be used to 
obtain representative data from conditioning experiments. In addition, naïve B cell 
activation and proliferation were successfully conditioned with a unique combination 
of anti-IgM, anti-CD40, IL-2, CpG, IL-21 and TGF-β1. In conclusion, based on the 
promising  data  generated,  IgA  is  expected  to  be  produced,  but  will  need  to  be 
confirmed. While further optimisation is required, the results of this project provide 
preliminary evidence that murine naïve B cells can be conditioned in vitro for IgA 
production, with potential for homing to, and protection of, mucosal surfaces in vivo.  
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Appendix A: Reagent List and Preparatio 
Reagent  Source  Catalogue Number 
2-mercaptoethanol   Sigma-Aldrich, St. Louis, MO  M3148-100ML 
Anti-mouse CD20 PE  eBioscience, San Diego, CA  12-0201-80 
Biotin hamster anti-mouse CD27   BD Biosciences, San Jose, CA  558753 
CellTrace CFSE Cell Proliferation Kit  Invitrogen, Carlsbad, CA  C34554 
Citric acid monohydrate  Rowe Scientific, Wangara, WA  CC3034 
Disodium hydrogen phosphate anhydrous  Merck, Kilsyth, VIC  6102490500 
Dulbecco’s phosphate buffered saline   Sigma-Aldrich, St. Louis, MO  D8537 
Ethanol absolute  Merck, Kilsyth, VIC  8187609020 
Fetal bovine serum   Invitrogen, Carlsbad, CA  10099-141 
Flow Cytometry Mouse Lyse Buffer (10x)  R&D Systems, Minneapolis, MN  FC003 
Halothane BP  Laser Animal Health, Sydney, NSW  Not available 
L-glutamine (200 mM solution)  Invitrogen, Carlsbad, CA  25030-149 
LIVE/DEAD Near-IR Fixable Cell Stain Kit  Invitrogen, Carlsbad, CA  L10119 
LPS from E. coli serotype R515  Enzo Life Sciences, Farmingdale, NY  ALX-581-007-L002 
Mouse anti-bovine IgG1  AbD SeroTec, Oxford, OXON  MCA627 
Mouse B Lymphocyte Enrichment Set   BD Biosciences, San Jose, CA  557792 
Mouse IgA Ready-SET-Go! ELISA kit  eBioscience, San Diego, CA  88-50450-86 
Mouse IL-2 recombinant protein  eBioscience, San Diego, CA  14-8021 
Mouse IL-21 recombinant protein  eBioscience, San Diego, CA  14-8211 
Mouse transforming growth factor β1   Cell Signaling Technology, Danvers, MA  5231LC 
Pacific Blue anti-mouse CD38  BioLegend, San Diego, CA  102719 
PE anti-mouse CD19  BioLegend, San Diego, CA  115507 Appendix 
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PE anti-mouse CD20  eBioscience, San Diego, CA  12-0201-80 
Purified anti-mouse CD40   eBioscience, San Diego, CA  14-0401 
Purified anti-mouse IgM  BioLegend, San Diego, CA  406502 
Purified rat anti-mouse CD16/32 (Mouse BD Fc Block)  BD Biosciences, San Jose, CA  553141 
RPMI 1640 media, no glutamine  Invitrogen, Carlsbad, CA  21870-092 
Sodium chloride  Sigma-Aldrich, St. Louis, MO  S9888 
Sodium dihydrogen orthophosphate dihydrate  Thermo Fisher Scientific, Scoresby, VIC  BSPSL950.500 
Sodium hydroxide  Thermo Fisher Scientific, Scoresby, VIC  BSPS6740.500 
Streptavidin APC  eBioscience, San Diego, CA  17-4317-82 
Sulphuric acid  Thermo Fisher Scientific, Scoresby, VIC  534-2.5L GL 
Trypan blue   Koch-Light Laboratories, Colnbrook, BUCKS  ML0553101 
Tween-20  Sigma-Aldrich, St. Louis, MO  274348 
Type B CpG oligonucleotide  InvivoGen, San Diego, CA  tlrl-1668 
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70% Ethanol 
300 ml absolute ethanol (EtOH) 
Make up to 1 L with distilled H2O  
0.4% (w/v) Trypan Blue Solution  
0.04 g trypan blue powder 
Make up to 10 ml with distilled H2O 
Filter precipitates with 0.45 µM filter 
10x Phosphate Buffered Saline (PBS) 
16.7 g disodium hydrogen phosphate (Na2HPO4) 
5.7 g sodium dihydrogen orthophosphate (NaH2PO4) 
85.0 g sodium chloride (NaCl ) 
Make up to 1 L with distilled H2O 
ELISA Wash Buffer (1X PBS + 0.05% Tween-20) 
100 ml 10X PBS  
0.5 ml Tween 20  
Make up to 1 L with distilled H2O 
ELISA Stop Solution 
27 ml concentrated H2SO4 in 450 ml of distilled water  
Make up to 500 ml with distilled H2O Appendix 
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5 M Sodium Hydroxide  
10.2 g sodium hydroxide (NaOH) 
Make up to 50 ml with distilled H2O 
20 mM Citrate Buffer pH 3.0 
0.4 g citric acid monohydrate 
Make up to 100 ml in distilled H2O  
Adjust to pH 3.0 with 5 M NaOH 
Filter sterilise with 0.2 µM filter 
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Appendix B: Animal Monitoring Sheet 
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